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 Axons degenerate following injury and during “dying-back” 
neurodegenerative diseases, which are characterized by early degeneration of 
synapses and axons. While injury and disease are clearly distinct events, they 
share some common regulators. Although these problems have been extensively 
studied, very little is known about which molecules initiate and execute the 
degeneration process. Uncovering mediators of axonal degeneration could 
provide new therapeutic targets for the treatment of neurodegenerative disease.  
This dissertation studies axon degeneration in the nematode 
Caenorhabditis elegans, where degeneration can be induced genetically or by 
injury. Axons degenerate in a manner consistent with Wallerian degeneration; 
they swell and fragment into debris particles that are engulfed by other cells. I 
have studied two main aspects of axon degeneration. First, I have shown that 
mitochondria are required to prevent the initiation of axon degeneration. I 
characterize a novel gene ric-7, which is required for mitochondrial export from 
neuronal cell bodies. In both ric-7 mutant and wild-type axons, degeneration is 
enhanced in the absence of mitochondria. Thus, mitochondria primarily protect 
axons and are not required for the execution of degeneration. Second, I have 
identified genes required for nonprofessional phagocytes to engulf neuronal 
  
debris following degeneration. I demonstrate that hypodermal cells engulf 
degenerating axons in C. elegans and that only some of the programmed cell 
death (ced) genes are involved. There are two parallel pathways that mediate 
engulfment of cell corpses during apoptosis; ced-1, -6, -7 and ced-2, -5, -10, -12. 
Both ced-1 and ced-6 are required for engulfment of degenerating axons, but not 
the parallel ced-2, -5, -12 pathway. Thus, epithelial cells engulf degenerating 
axons in a manner that is distinct from both apoptosis and macrophage/glia-
mediated engulfment of degenerating axons. C. elegans will be a useful model 
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Breakdown of neuronal processes occurs during developmental pruning, 
neurodegenerative disease, and following an injury. While degeneration is 
typically thought of as detrimental, it can serve a beneficial purpose. The pruning 
of axons and dendrites during development is essential for establishing functional 
neuronal networks (Luo and O’Leary, 2005). Degeneration of injured axons is 
also beneficial to an organism because regrowth is impaired if damaged axons 
are not removed (Hosmane et al., 2012; Tanaka et al., 2009). However, axon 
destruction programs are inappropriately activated in neurodegenerative 
diseases. Some diseases clearly involve the death of the whole cell, while others 
are considered “dying-back” neurodegeneration (Coleman and Freeman, 2010; 
Dadon-Nachum et al., 2011; Han et al., 2010; Kanaan et al., 2013). In “dying-
back” diseases, the synapses and axons break down a substantial time before 
the cell body dies. One model to explain the “dying-back” phenomenon is that a 
prodegeneration signal in distal axons is transmitted back to the cell body over 
time. In this model, preventing the degeneration of synapses and axons may 
quell the disease as a whole.  
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Although pruning, neurodegenerative disease, and injury-induced 
degeneration are clearly distinct events, they do share multiple characteristics. 
First, the breakdown process in all three of these events follows a progression of 
stereotyped morphological changes commonly referred to as Wallerian 
degeneration. They swell and fragment into smaller particles that are cleared 
away by other cells through engulfment. Second, caspase signaling mediates 
both pruning and degeneration following injury (Kuo et al., 2006; Nikolaev et al., 
2009; Schoenmann et al., 2010; Williams et al., 2006). Third, the protective 
chimeric protein Wlds can suppress degeneration in both disease and injury 
models (Beirowski et al., 2004; Ferri et al., 2003; Howell et al., 2007). Lastly, 
genes required for the clearance of fragmented neurites are shared between 
pruning, injury-induced degeneration, and neurodegeneration (Awasaki et al., 
2006; Chung et al., 2000; Macdonald et al., 2006). Thus, investigating the 
molecular underpinnings of axon degeneration is a means to understand 
neuronal development and response to injury, as well as to uncover therapeutic 
targets for the treatment of neurodegenerative diseases. 
 
Wallerian Degeneration 
Augustus Waller (1816-1870) characterized the destruction of axons 
following an injury. Waller severed the glossopharyngeal and hypoglossal nerves 
of the frog tongue and observed the morphological changes occurring over time 
(Waller, 1850). He made three critical observations that have proven over the 
past century and a half to be hallmarks of axon degeneration. First, he noted that 
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the nerves break down by dissociating into increasingly smaller granules. 
Second, he observed that this fragmentation process was most severe at the 
extremities of the nerves. And third, he stated that the granules were “removed 
by absorption.” He also aptly speculated that the destruction he was observing 
might be related to prolonged disease states in humans. Due to the seminal 
nature of this work, the breakdown of nerve fibers has subsequently been 
referred to as Wallerian degeneration. A legion of studies has since corroborated 
Waller’s foundational discoveries. Injured axons first swell and then fragment into 
dissociated granules of debris that are eventually cleared away by other cells 
through engulfment (Wang et al., 2012). Fragmentation progresses anterograde 
from the lesion site after complete transection of an axon and retrograde from the 
distal tip after a crush injury (Beirowski et al., 2005). 
 
WldS 
 The study of Wallerian degeneration took a profound turn with the 
discovery of a spontaneous mutation that protected mice against neuronal injury 
(Lunn et al., 1989). The mutation was named WldS for slow Wallerian 
degeneration. WldS is a tandem triplication that creates a chimeric protein fusion 
between the N-terminal 70 amino acids of ubiquitination factor E4B (Ube4b) and 
nicotinamide mononucleotide adenylyltransferase 1 (Nmnat1) (Coleman et al., 
1998; Mack et al., 2001). The discovery of the neuroprotected WldS mice 
provided evidence that Wallerian degeneration is a genetically encoded and 
regulated process, rather than the passive decay of tissue.  
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The specific mechanism of WldS neuroprotection is not clear. However, 
Nmnat is known to provide the neuroprotective activity, while the Ube4b domain 
mediates subcellular localization. Nmnat is an NAD+ synthesis enzyme. There 
are three Nmnat proteins in mice, each with a unique subcellular localization; 
nucleus (Nmnat1) (Berger et al., 2005), Golgi transport vesicles (Nmnat2) (Gilley 
and Coleman, 2010; Milde et al., 2013), and mitochondria (Nmnat3) (Berger et 
al., 2005). Both Nmnat1 and 3 are axon protective when overexpressed, whereas 
Nmnat2 is not protective unless highly overexpressed due to its short half-life 
(Avery et al., 2009; Gilley and Coleman, 2010; Sasaki et al., 2006). The Ube4b 
fragment in WldS increases the axon localization of the fusion protein. Localizing 
WldS to axons must be the important contribution of the Ube4b fragment, since 
Nmnat1 is just as potent as WldS at protecting axons if its endogenous nuclear 
localization signal is replaced with an axon localization signal (Babetto et al., 
2010; Beirowski et al., 2009; Sasaki et al., 2009a). Despite the multitude of 
studies on WldS over the past decade, its mechanism of action is still widely 
debated. There are three models for WldS mechanism of protection: NAD+ 
synthesis, altering mitochondria dynamics, and chaperoning synaptic proteins. 
 
NAD+ synthesis 
 The importance of Nmnat’s enzymatic activity remains controversial. 
Several studies have shown that Nmnat enzyme activity is required for its axon 
protection effects (Araki et al., 2004; Avery et al., 2009; Jia et al., 2007; Sasaki et 
al., 2009b; Yan et al., 2010). In contrast, two studies from Drosophila have 
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demonstrated that enzymatically dead Nmnat can still robustly protect axons 
after an injury (Kitay et al., 2013; Zhai et al., 2006). Exogenous application of the 
enzymatic product, NAD+, can protect axons (Araki et al., 2004; Wang et al., 
2005a), although this result is not consistent between different studies (Conforti 
et al., 2007; Sasaki et al., 2009b). And while Nmnat activity is increased in WldS 
neurons, the NAD+ levels are not (Mack et al., 2001). In conclusion, the 
conflicting results regarding the importance of Nmnat’s enzymatic activity 
suggest that while NAD+ likely affects neuronal stability, NAD+ synthesis is not 
likely to be the only mechanism of protection for WldS. 
 
Mitochondria 
 Recent reports suggest that an important function of WldS is to regulate 
mitochondria function or trafficking. Nmnat3 is localized to mitochondria and can 
robustly protect axons when overexpressed (Avery et al., 2009; Berger et al., 
2005; Sasaki et al., 2006). RNAi against Drosophila Nmnat results in age-
dependent depletion of mitochondria from axons in the wing (Fang et al., 2012). 
WldS mitochondria are capable of buffering a greater amount of calcium and 
have increased mobility in axons following an injury compared to wild-type 
mitochondria (Avery et al., 2012; O’Donnell et al., 2013).  
WldS axon protection depends on proper mitochondria transport. 
Decreased WldS mitochondria mobility in hypomorphic mutants of the transport 
adaptor miro suppresses the axon protective effects of WldS (Avery et al., 2012). 
In a separate study, knockdown of another mitochondria transport adaptor milton 
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resulted in spontaneous degeneration of axons in the adult fly wing. The 
spontaneous axon degeneration could not be suppressed with WldS or 
overexpression of Nmnat (Fang et al., 2012). These data suggest that 
mitochondria are critical for the protective mechanism of WldS. 
 
Chaperone 
 Perhaps the most intriguing model for WldS function is its proposed action 
as a chaperone. Grace Zhai’s laboratory has demonstrated that an enzymatically 
dead WldS can still protect axons, even in the complete absence of mitochondria 
(Kitay et al., 2013; Zhai et al., 2006). They demonstrate that in the absence of 
Nmnat, the synaptic protein Bruchpilot is degraded and synapses are 
destabilized (Zang et al., 2012). However, while loss of Nmnat destabilized 
Bruchpilot T-bar structures at the active zone, neuromuscular junction and motor 
neuron axon degeneration were not demonstrated. Similarly, there have not been 
reports of Bruchpilot mutants exhibiting neurodegeneration. Perhaps Nmnat is 
stabilizing multiple synaptic proteins and the loss of Bruchpilot alone is 
insufficient to induce the neurodegeneration frequently observed after loss of 
Nmnat.  
 
Towards an integrated model 
Our current understanding of WldS-mediated neuronal protection comes 
from Drosophila and mammalian model organisms using several different 
experimental protocols for inducing degeneration. It is plausible that different 
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neuronal insults require protective factors like WldS to varying degrees. To 
properly interpret the results above, we must consider the three methods used to 
induce neurodegeneration: axon damage (crushing), axon transection, and 
degeneration in the absence of injury. 
Studies from Drosophila present conflicting results for the role of 
mitochondria in Nmnat-mediated axon protection. Hypomorphic mutations in miro 
suppress the protective effects of WldS after laser axotomy of the olfactory 
receptor neurons (Avery et al., 2012); but, knockout of milton has no effect on 
WldS protection of crushed motor neuron axons. Perhaps WldS protects axons 
through multiple mechanisms and the type of injury is critical. Crush injuries 
proceed retrogradely from the distal axon (Beirowski et al., 2005). Thus, in a 
motor neuron crush injury, WldS may be protecting the axons by stabilizing 
Bruchpilot at the neuromuscular junctions. By contrast, complete transection of 
an axon leads to fragmentation proceeding anterogradely, beginning at the lesion 
site (Beirowski et al., 2005). Complete transection likely results in a larger 
calcium influx at the lesion site, and protecting axons from transection may 
therefore require mobilizing mitochondria and increasing their buffering capacity. 
However, WldS was also unable to protect against retrograde degeneration of 
axons in the fly wing after knockdown of milton (Fang et al., 2012). In this case, 
there was no injury to the cell; thus, these experiments represent yet another 
class of axon degeneration. It will be important for future studies to resolve 
whether these discrepancies are due to variations in the injury method or neuron 
type. It will also be interesting to see if roles for WldS in both chaperoning and 
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mitochondria dynamics can be observed in mammalian systems as well. 
 
Limitations of WldS 
 WldS is not always protective. Perhaps most intriguing are the results for 
WldS in developmental pruning. WldS does not suppress axon pruning in 
Drosophila (Hoopfer et al., 2006), but surprisingly, it can inhibit dendritic pruning 
(Schoenmann et al., 2010; Tao and Rolls, 2011). In addition to axon pruning, 
WldS has been reported to have no effect on various neurodegenerative disease 
models, including ALS and spinal muscular atrophy, both of which are 
considered to be dying-back diseases with axonal defects arising before the 
death of the cell (Kariya et al., 2009; Rose Jr. et al., 2008; Velde et al., 2004).  
The rules governing the degeneration of neuronal processes are still 
murky at best. There are undoubtedly different types of degeneration with unique 
molecular mediators of destruction. However, at this time it is unclear as to how 
various types of degeneration can be categorized. Where do they overlap and 
differentiate from one another? For example, does dendritic pruning have more in 
common with axon degeneration than axon pruning? Because WldS is one of the 
most widely tested molecules in degeneration, it may be the first step in 
categorizing types of neural degeneration. Elucidation of the mechanisms behind 
WldS may help parse the various forms of axon degeneration into functional 
categories. 
Up until the last couple of decades, Wallerian degeneration was defined 
exclusively by its characteristic morphological changes. In recent years, WldS has 
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become the gold standard of Wallerian degeneration. However, it is important to 
acknowledge that WldS represents a mechanism of axon protection, and not 
necessarily a mechanism of axon destruction. WldS could be acting to directly 
inhibit an axon destruction program (Figure 1.1A), in which case it is a reliable 
readout of the actual degeneration process. Alternatively, WldS could be acting in 
parallel to destruction programs by over-activating a survival mechanism (Figure 
1.1B). In other words, it could be promoting a protective function within the axon 
that is independent of the executers of axon degeneration. There are 
undoubtedly multiple ways to kill an axon. Do each of these mechanisms end 
with the same fragmentation, beading, and removal of axons, i.e., Wallerian 
degeneration? How likely is it that WldS will also suppress each mechanism of 
axon destruction? WldS has provided a valuable inroad to the molecular study of 
Wallerian degeneration, but until its function is finally resolved, it is difficult to 
know whether it is an appropriate redefinition of Wallerian degeneration. 
 
The Role of Mitochondria in Degeneration 
Many neurodegenerative disorders are associated with mitochondrial 
defects. However, due to the vast complexity of most neurological diseases, it is 
difficult to resolve the role of mitochondria within degeneration. While a select 
number of diseases do arise directly from mutations affecting mitochondria 
(Alexander et al., 2000; Delettre et al., 2000; Züchner et al., 2004), the vast 
majority of diseases involve indirect impairment of mitochondria. But even the 
indirect mitochondrial deficits may be playing an early and influential role in  
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disease progression. In diseases that are primarily sporadic, such as 
Alzheimer’s, mitochondrial defects are often observed before other hallmarks of 
pathology become detectable (Manczak, 2006; Nunomura et al., 2001; Praticò et 
al., 2001).  
Despite the extensive amount of research on mitochondria within 
neurodegeneration models, the exact role of mitochondria is still debated. It 
remains to be established whether mitochondria play a protective or destructive 
role within degeneration (Figure 1.2). In other words, axonal demise could arise 
from the loss of a survival role or from the acquisition of a toxic role. 
Compromised mitochondria may be unable to protect the cell and support axonal 
maintenance. In this case, a decrease in energy or calcium buffering could lead 
cells down a path of gradual destruction. Alternatively, mitochondria may play an  
active and toxic role in neurodegeneration through the release of reactive oxygen 
Figure 1.1 WldS models. (A) WldS may be functioning to inhibit molecules that 
are involved in breaking down axons. In this model, WldS is suppressing the 
prodegenerative signaling to prevent axon degeneration from occurring. (B) 
WldS may be functioning in parallel to an axon degeneration pathway. In this 
model, WldS is augmenting an axon survival pathway such that it overwhelms 
any prodegenerative signaling. 









Figure 1.2. The potential roles for mitochondria in protecting and 
destroying axons. (A) Mitochondria can protect axons by supplying 
energy (ATP) and buffering cytosolic calcium, which might otherwise 
initiate degeneration signaling. (B) Mitochondria are known to participate in 
the destruction of cells through the production of reactive oxygen species 
(ROS) and the opening of the mitochondrial permeability transition pore 
(mPTP, orange), which releases calcium and apoptosis factors into the 
cytosol. Mitochondria may be playing a similar role in the destruction of 
severed axons. 
	   12 
species (ROS) and apoptotic factors.  
 
Energy supply 
 Oxidative phosphorylation, or the supply of ATP, is a critical function for 
mitochondria. The nervous system consumes a disproportionately large amount  
of energy in the human body. Much of this energy consumption is dedicated to 
reversing ion fluctuations following an action potential in order to restore the 
resting membrane potential (Harris et al., 2012). Insufficient ATP levels are likely 
to result in the failure of Na+/K+ pumps, which will lead in an accumulation of Na+ 
within the neuron. High Na+ levels will in turn reverse the direction of the 
Na+/Ca2+ exchanger, resulting in a detrimental influx of calcium into the cell 
(Mandolesi et al., 2004; Stys et al., 1992). A more recent study demonstrates that 
the greatest ATP sink in neurons is synaptic vesicle recycling (Rangaraju et al., 
2014). Thus, preventing neuronal activity should enhance ATP levels by 
removing the need for energy expenditure on synaptic vesicle recycling and 
membrane potential maintenence. If ATP levels are critical for axon survival, 
inhibiting neuronal activity should be neuroprotective. However, the data are 
conflicting; inhibition of neuronal activity is neuroprotective in some cases 
(Garthwaite et al., 2002; Kapoor et al., 2003; Wolf et al., 2001; Zhai et al., 2006) 
and ineffective in others (George et al., 1998; Press and Milbrandt, 2008). 
Considering that oxidative phosphorylation is not important for maintaining 
resting levels of ATP (Rangaraju et al., 2014), it seems unlikely that ATP supply 
from mitochondria is critical for axon maintenance.  
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Calcium buffering 
Calcium is important in cell signaling and is tightly regulated by the cell. A 
role for excess calcium in promoting degeneration has been repeatedly 
demonstrated (reviewed in Wang et al., 2012; Zündorf and Reiser, 2011). For 
example, calcium channel blockers and calcium chelators can impede axon 
degeneration (Barrientos et al., 2011; George et al., 1998; Knöferle et al., 2010). 
Although mitochondria have not directly been shown to buffer calcium following 
an injury, indirect evidence suggests that they do. The calcium rise in injured 
WldS axons is significantly reduced, and isolated WldS mitochondria are able to 
load significantly greater amounts of calcium in vitro (Avery et al., 2012). The role 
of mitochondria in buffering calcium is discussed further in Chapter 4. 
 
Reactive oxygen species 
Evidence suggests that mitochondria are also involved in the destruction 
of axons. Elevated levels of ROS have been shown to induce degeneration 
(Alvarez et al., 2008; Koeberle and Ball, 1999; Lucius and Sievers, 1996) and 
mitochondria are the primary source of ROS (Shigenaga et al., 1994). The 
amounts of detectable ROS are enhanced in models of multiple 
neurodegenerative diseases (Alam et al., 1997; Bogdanov et al., 2001; Browne 
et al., 1997; Ferrante et al., 1997; Krebiehl et al., 2010; Manczak, 2006; Wang et 
al., 2005b). Furthermore, antioxidant treatments can ameliorate disease states 
(reviewed by Bastianetto and Quirion, 2004). For example, treatment of neurons 
with rotenone, an electron transport chain inhibitor, dramatically increases ROS 
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levels and induces degeneration, but application of the antioxidant Vitamin E 
robustly protected the axons from degeneration (Press and Milbrandt, 2008). 
Thus, ROS generation by dysfunctional mitochondria may be an important 
regulator of neurodegeneration. 
 
Apoptosis and the mPTP 
Other studies have shown that mitochondria are active in the process of 
degeneration through the mitochondria permeability transition pore (mPTP) and 
apoptosis pathway. The mPTP is thought to open after mitochondria are 
overloaded with calcium. Opening of the mPTP releases both calcium and the 
apoptotic factor cytochrome C into the cytosol (Correia et al., 2010). Hallmarks of 
mPTP, such as mitochondrial swelling and decreased membrane potential, are 
frequently observed in disease models (Casley, 2002; Cassarino et al., 1999; 
Choo, 2004; Hsu et al., 2000; Moreira et al., 2001, 2002; Song et al., 2004). 
Blocking or eliminating a key component of the mPTP, cyclophilin D, can 
ameliorate disease conditions (Borlongan et al., 1996; Cassarino et al., 1999; 
Choo, 2004; Du et al., 2008; Kim et al., 2002; Matsuura et al., 1996; Okonkwo 
and Povlishock, 1999). A recent study by Barrientos et al. has shown that the 
mPTP is likely required for axon degeneration (Barrientos et al., 2011). 
Several apoptosis pathway members have been shown to participate in 
the process of degrading axons (Keller et al., 2011; Kuo et al., 2006; 
Schoenmann et al., 2010; Williams et al., 2006). The role of apoptosis 
components in axon degeneration is discussed further in Chapter 3. 
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Are mitochondria required for axon degeneration? 
Recent studies demonstrate that mitochondria are actively participating in 
axon degeneration. Mitochondria may have a role in initiating degeneration. The 
degeneration of motor neuron axons following a crush injury was significantly 
delayed in milton knockouts that lack mitochondria in axons (Kitay et al., 2013). 
Eight hrs after the crush injury, over 60% of wild-type axons were fragmented, 
whereas only ~20% of the milton knockout axons were fragmented. By 16 hrs, 
they were both fully fragmented. Thus, the milton knockout axons were not 
protected from degeneration but had a delayed onset, suggesting that 
mitochondria normally play a role in initiating axon degeneration.   
Other studies suggest that mitochondria are more strictly required for the 
execution of axon degeneration. Severed axons cultured in the presence of an 
mPTP inhibitor were protected from axon degeneration, arguing that 
mitochondria are acting locally in the destruction of axons (Barrientos et al., 
2011). Additionally, the loss of mitochondria was protective in an alpha-spectrin 
disease model (Keller et al., 2011). Knockdown of alpha-spectrin leads to the 
degeneration of neuromuscular junctions. Mutating the mitochondrial transport 
gene miro reduced the number of mitochondria in axons and suppressed 
neuromuscular junction degeneration. In other words, removing mitochondria 
from the axon abates degeneration, suggesting that mitochondria are required for 
this process to occur. 
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Dissertation Outline 
 In this dissertation, I will characterize axon degeneration in C. elegans and 
demonstrate the critical role for mitochondria in axon survival. The nematode has 
not previously been used for the study of axon degeneration following an injury. 
In addition to establishing the utility of this model system, I also tested several 
controversial mediators of axon degeneration. In Chapter 2, I demonstrate that 
the decision for an axon to degenerate or remain stable is dependent upon the 
localization of mitochondria. These experiments reveal that mitochondria potently 
protect axons and are not required for the execution of axon degeneration. 
Chapter 2 also contains the characterization of ric-7, a novel regulator of 
mitochondrial transport. In Chapter 3, I investigate the role of the apoptosis 
pathway in both injury-induced axon degeneration and in a beta-spectrin 
neurodegeneration model. The caspase ced-3 is likely involved in the 
fragmentation of degenerating axons and the engulfment genes ced-1 and ced-6 
are required for the removal of fragmented axons. The engulfment gene ced-7 
was only required in the beta-spectrin mutants, suggesting that ced-7 may be 
uniquely regulated depending on the type of axon degeneration. In Chapter 4, I 
discuss preliminary and future experiments that will elucidate the mechanisms of 
mitochondria-mediated axon protection and RIC-7 function. 
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AXONS DEGENERATE IN THE ABSENCE OF  




 Many neurodegenerative disorders are associated with mitochondrial 
defects (Chang et al., 2006; Patten et al., 2010; Schon and Przedborski, 2011). 
Mitochondria can play an active role in degeneration by releasing reactive 
oxygen species and apoptotic factors (Alvarez et al., 2008; Koeberle and Ball, 
1999; Lucius and Sievers, 1996; Shigenaga et al., 1994). Alternatively, 
mitochondria can protect axons from stress and insults, for example by buffering 
calcium (Avery et al., 2012). Recent studies manipulating mitochondria lend 
support to both of these models (Barrientos et al., 2011; Fang et al., 2012; Iijima-
Ando et al., 2012; Keller et al., 2011; Kitay et al., 2013). Here, we identify a 
C. elegans mutant, ric-7, in which mitochondria are unable to exit the neuron cell 
bodies, similar to the kinesin-1/unc-116 mutant. When axons lacking 
mitochondria are cut with a laser, they rapidly degenerate. Some neurons even 
spontaneously degenerate in ric-7 mutants. Degeneration can be suppressed by 
forcing mitochondria into the axons of the mutants. The protective effect of 
mitochondria is also observed in the wild type: a majority of axon fragments 
  
26 
containing a mitochondrion survive axotomy, whereas those lacking mitochondria 
degenerate. Thus, mitochondria are not required for axon degeneration and 
serve a protective role in C. elegans axons. 
 
Highlights 
• ric-7 and kinesin-1 are required for localization of mitochondria to axons. 
• Axons lacking mitochondria rapidly degenerate after axotomy. 
• In wild-type worms, mitochondria prevent axon degeneration. 




ric-7 mutants have impaired neurotransmission 
We identified a novel gene ric-7 (resistant to inhibitors of cholinesterase) 
that is essential for mitochondrial localization in axons. Alleles were isolated in 
unrelated genetic screens either for mutants with neurotransmission defects or 
for mutants with abnormal axon morphology. The ric-7 locus was identified by 
positional cloning and was also described by Hao et al. (Hao et al., 2012). 
Microinjection of cosmid F58E10 rescued ric-7 mutants, and microinjection of 
PCR fragments localized the rescuing activity to an 18 kilobase sequence 
predicted to contain two open reading frames, F58E10.1 and F58E10.7 (Figure 





identified the molecular lesions associated with the three ric-7 alleles. All alleles 
contain mutations in predicted exons of F58E10.1 (Figure 2.1B, Table 2S.1). The 
potential functions of RIC-7 were not obvious from the sequence; the RIC-7 
protein lacks conserved domains and has rapidly diverged even among 
nematodes (Figure 2S.1A).  
Both acetylcholine and GABA neurotransmission are impaired in ric-7 
mutants. Wild-type animals become paralyzed and die upon exposure to an 
acetylcholinesterase inhibitor Aldicarb. Paralysis is due to a build up of 
Figure 2.1. Cloning of ric-7. (A) The mutation n2657 was mapped to the 
interval on chromosome V between lin-25 and unc-76. Cosmid F58E10 (purple 
bar) spans 41 kilobases in this interval and rescued ric-7 mutants as a 
transgene. Further experiments using PCR fragments indicated that rescuing 
activity was contained in an 18 kilobase (kb) fragment that contains two 
hypothetical genes, F58E10.1 and F58E10.7. (B) All five ric-7 alleles contain 
alterations in F58E10.1 exons (see Table 2S.1). Arrows mark the locations of 
premature stops. ox134 is a large deletion affecting three genes. 
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acetylcholine in the synaptic cleft; thus, animals with impaired acetylcholine 
release are slower to respond to the drug. ric-7 mutants are resistant to the 
effects of Aldicarb (Hao et al., 2012) (Figure 2S.1B). GABA neurotransmission is 
also disrupted in ric-7 mutants. In C. elegans, defecation is a programmed 
behavior that requires GABA release onto the enteric muscles (Liu and Thomas, 
1994; McIntire et al., 1993a).  ric-7(n2657) animals are constipated due to the 
absence of enteric muscle contractions (Hao et al., 2012) (Figure 2S.1C). 
Restoring ric-7 exclusively to GABA neurons using the unc-47 promoter rescues 
the mutant defecation phenotype (‘RIC-7(+)’), demonstrating that RIC-7 acts cell 
autonomously. These results demonstrate that mutations in ric-7 disrupt both 
GABA and acetylcholine neurotransmission, suggesting that ric-7 is generally 
required for synaptic transmission in C. elegans.  
In spite of defects in neurotransmission, ric-7 mutants have normal 
presynaptic structures. The active zone protein RIM (UNC-10), the synaptic 
vesicle protein vGAT (UNC-47), and the dense core vesicle protein FLP-3 are 
normally distributed along axons (Figure 2S.1G-I). Wild-type and mutant animals 
have a similar density of synaptic puncta in GABA motor neurons (Figure 
2S.1D,E). ric-7 synapses also appear normal at the ultrastructural level; 
specifically, there is no alteration in synaptic vesicle number (Figure 2S.1F,J). 
Consistent with the normal appearance of synapses, ric-7 mutants exhibit normal 





Mitochondria are absent in axons of ric-7 mutants 
A transcriptional reporter construct indicates that the ric-7 gene is 
expressed in most neurons and head muscles (Figure 2S.1K). A translational 
reporter construct (Figure 2S.2A) suggests that RIC-7 can associate with 
mitochondria. N-terminally tagged RIC-7 (RFP::RIC-7) can rescue ric-7 mutants 
when expressed on extrachromosomal arrays, and fluorescence colocalizes with 
the mitochondrial marker Tom20::GFP, ‘mito::GFP’ (Figure 2.2A). Single copy 
insertions were dim or not visible (Fig 2S.2B). 
To determine whether mitochondria are altered in ric-7 mutants, we 
examined the distribution of GFP-tagged mitochondria in wild-type and mutant 
animals. In the wild type, mitochondria are distributed along the entire axon. 
However, in ric-7 mutants, mitochondria are located almost exclusively in the cell 
bodies (Figure 2.2B,C). Occasionally, one or two mitochondria can be seen in 
proximal axons on the ventral side, typically near the cell body, whereas the 
distal axons in the dorsal nerve cord are completely void of mitochondria in ric-7 
mutants (Figure 2S.2C). This suggests that in the few cases where mitochondria 
are able to exit the cell body, they cannot make it far in the absence of RIC-7. 
This mitochondrial distribution closely resembles that of the strong hypomorphic 
allele of kinesin-1, unc-116(rh24sb79). The other predominant kinesin in C. 
elegans motor neurons, kinesin-3/unc-104, is not required for trafficking of 
mitochondria out of the cell bodies (Figure 2.2B,D). Expressing N-terminally 
tagged RIC-7 (RFP::RIC-7) in ric-7 mutants rescues the mitochondrial distribution 

















Figure 2.2. RIC-7 colocalizes with mitochondria and is required for 
mitochondrial distribution in axons. (A) Tagged RIC-7 expressed in GABA 
neurons (Punc-47:RFP::RIC-7, oxEx1598) rescues ric-7 mutants and 
colocalizes with mitochrondria tagged with Tom20::GFP (‘mito::GFP’). Worms 
were imaged with the dorsal nerve cord facing the objective. See also Figure 
2S.2A,B. (B) Mitochondria tagged with Tom20::GFP are trapped in the cell 
body and absent from axons in ric-7 and kinesin-1/unc-116 mutants but not 
kinesin-3/unc-104 mutants. Arrowheads indicate cell bodies, and arrows point 
to axonal mitochondria. Asterisks indicate gut autofluorescence. See also 
Figure 2S.2C,D. Worms were imaged with the ventral nerve cord facing the 
objective. All scale bars are 10 µm. (C) Average number of mitochondria per 
50 µm in the ventral nerve cord of GABA motor neuron axons +/- SEM. 
Mitochondrial distribution is rescued cell autonomously in axons when 
RFP::RIC-7 is expressed from an array (‘RIC-7(+)’, oxEx1598). p < 0.0001 
Kruskal-Wallis test with Dunn’s multiple comparisons to the wild type (black) 






























Mitochondrial distribution within other cell types, including muscle and 
hypodermis, is normal in ric-7 mutants, indicating that ric-7 does not have a 
general role in mitochondrial localization (Figure 2S.2D,E). Other organelles such 
as synaptic vesicles and dense core vesicles are normally distributed in ric-7 
mutant axons (Figure 2S.1H,I). These data suggest that ric-7 is specifically 
required for the localization of mitochondria in neurons.   
 
Axon degeneration is enhanced in ric-7 mutants 
 Axons from two neurons, PVQ and HSN, spontaneously degenerate in the 
absence of mitochondria. Mutations in ric-7 were identified in an axon 
morphology screen because they had truncated PVQ axons in adult worms. 
However, the truncation is not due to an outgrowth defect; PVQ axons in ric-7 
mutants extend normally during embryogenesis and remain largely intact during 
the first three larval stages (Figure 2.3A,B). However, at the beginning of the 
fourth larval stage, the axons begin to swell and degenerate (Figure 2.3C). By 
adulthood, most PVQ axons are truncated, typically near the vulva (Figure 2.3D). 
The proximal axon and cell body remain intact for the remaining life of the worm. 
The HSN axons, which grow out during early larval stages, degenerate in a 
similar fashion during early adulthood in ric-7 mutants (Figure 2S.3B-E).  
Remarkably, the majority of axons in ric-7 mutants remain stable 
throughout the life of the worm. Thus, ric-7 mutants provide a tool to address 
whether mitochondria are required for axonal degeneration. Severing the axon in 












Figure 2.3. Axon degeneration is enhanced in the absence of 
mitochondria. (A) PVQ axons spontaneously degenerate in ric-7 mutants. 
The degenerating axons proceed through the following morpholigies; swollen, 
beaded, and finally truncated. The percentage of axons with a given 
morphology is depicted for each life stage of ric-7(zd152). The number of 
worms assayed is indicated. (B) In the first larval stage, PVQ axons are intact 
in ric-7(zd152) mutants. GFP is expressed in PVQ and head neurons (ASH, 
ASI) under the sra-6 promoter. The two PVQ cell bodies are in the tail; each 
extends an axon along the ventral nerve cord to the head. (C) During the 
fourth larval stage, the distal portion of the axon degenerates, beginning with 
swellings. (D) PVQ axons are typically truncated, frequently near the vulva, by 
the end of the fourth larval stage. The proximal half of the axons and the cell 
bodies remain intact. Scale bar = 100 µm. See also Figure 2S.3A-E. (E) 
GABA motor neuron axons degenerate following laser axotomy. Arrowheads 
point to the cut sites in the image taken immediately after axotomy. There are 
three severed axons (numbered). (F) After 24 hrs of recovery, worms were 
reimaged and the presence or absence of severed axons was scored. The 
wild-type panel is the same worm from panel E. Two of the three axons 
exhibit swellings but are still present. Severed motor neuron axons completely 
degenerate in ric-7 and kinesin-1/unc-116 mutants. Scale bar = 25 µm. (G) 
The average percent of axons that are still present 24 hrs after axotomy +/- 
SEM. More axons degenerate in mutants lacking mitochondria compared to 
the wild type. The kinesin-3/unc-104 mutant, which has mitochondria 
throughout their axons, degenerates at wild-type levels. p < 0.0001 Kruskal-
Wallis test with Dunn’s multiple comparisons to the wild type, *** p<0.001, 










from the influence of mitochondria. To determine the role of mitochondria in 
axonal degeneration, GABA motor neuron axons were cut using a laser in ric-7 
mutants and wild-type animals. Motor neuron axons cross from the ventral to the 
dorsal cord in single axon commissures. The axons were visualized by 
expressing a soluble GFP under the unc-47 (vGAT) promoter. Four to five 
commissures were severed in the posterior of L2 worms, typically 3 VD and 1-2 
DD axons. The cell bodies were subsequently killed with the laser to prevent the 
regeneration of new axons, which would obscure the degenerating distal axons. 
After 24 hrs of recovery, the worms were reimaged and the presence of 
commissures was scored. In wild-type worms, 58% of the GABA axons are 
present after 24 hrs, whereas no axons remain in ric-7 mutants (Figure 2.3F,G). 
To determine whether additional cell types are hypersensitive to 
degeneration in ric-7 mutants, we also performed axotomy on acetylcholine 
motor neurons and the ALA neuron. We expressed membrane-bound GFP under 
the acr-5 promoter, which expresses in the acetylcholine DB motor neurons, 
ALA, and neurons in the head and tail ganglia. Two DB commissures were 
severed in each worm and then scored after 24 hrs for their presence or 
absence. Only 11% of ric-7 acetylcholine motor neuron axons remained after 24 
hrs, whereas 84% of wild-type axons were still present (Figure 2S.3F). The ALA 
axon also displayed robust degeneration after injury in ric-7 mutants. The ALA 
neuron sends out two axons that run from the head to the tail on each side of the 
worm. Severed ALA axons are still present 24 hrs after axotomy in the wild type; 
however, in ric-7 mutants, severed axons completely degenerate (Figure 
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2S.3G,H). Interestingly, injured axons are quite stable in wild-type C. elegans, 
which has been previously noted within regeneration studies (Pinan-Lucarre et 
al., 2012; Wu et al., 2007). In all three cell types tested, ric-7 mutants exhibited 
robust levels of axon degeneration. 
 
Mitochondrial localization mutants have  
enhanced degeneration 
 If the enhanced degeneration in ric-7 mutants is due to the loss of 
mitochondria, then other mutants with abberrantly localized mitochondria should 
also have increased levels of axon degeneration. To test this, we performed laser 
axotomy on kinesin-1 mutants, which also have a severe loss of mitochondria in 
their GABA motor neuron axons (Figure 2.2B,C). Similar to ric-7, the vast 
majority of injured axons degenerate in kinesin-1 mutants (Figure 2.3F,G). 
Kinesin-1 mutants could have increased degeneration due to their severe health 
impairments or to a general disruption in axonal transport. However, mutants for 
kinesin-3/unc-104, which are equally unhealthy and deficient for key axon 
components such as synaptic vesicles (Hall and Hedgecock, 1991), have wild-
type levels of degeneration (Figure 2.3F,G).  
We additionally tested worms overexpressing a dominant negative form of 
DRP-1 (dynamin-related protein) in GABA neurons. DRP-1 is required for 
mitochondrial fission (Otsuga et al., 1998; Smirnova et al., 1998), and neurons 
overexpressing a dominant-negative version DRP-1(K40S) have long tubular 
mitochondria extending from the cell body into the proximal axons, but 
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mitochondria numbers are reduced in the distal axons. When these axons 
lacking mitochondria are cut, they rapidly degenerate; only 23% of the axons 
remain after 24 hrs (compared to 58% in the wild type, Figure 2S.3I-K). Of these 
surviving axons, 70% contained visible escapee mitochondria when inspected. 
Thus, absence of mitochondria leads to an enhancement in axon degeneration in 
a variety of mutants. 
 
Mitochondria prevent axon degeneration in  
wild-type animals 
To determine whether mitochondria mediate axon survival in healthy 
animals as well, we performed experiments on wild-type ALA axons. The ALA 
axon is long and has a naturally sparse distribution of mitochondria, 
approximately 1 mitochondrion per 100 µm (0.47 ± 0.05 mitochondria per 50 µm, 
n= 17 L2 worms). To isolate axon segments that were void of mitochondria, the 
ALA axon was cut into multiple pieces. Because these axon segments recieve a 
calcium influx through two lesion sites, they may be especially sensitive to the 
calcium buffering capacity of mitochondria. Each worm was imaged immediately 
following axotomy; roughly half of the fragments contained mitochondria (61%). 
24 hrs later, axon segments were scored for survival. 72% of axon segments 
containing mitochondria survived, whereas only 26% of segments lacking visible 
mitochondria survived (Figure 2.4A-C). Thus, the absence of mitochondria 
promotes degeneration in both mutant and wild-type axons.  









Figure 2.4. Mitochondria mediate axon protection. (A) The presence of 
mitochondria protects axons from degeneration in a wild-type background. ALA 
axons are labeled by expressing membrane-bound GFP under the acr-5 
promoter (‘axon::GFP’) and mitochondria are labelled by expressing mito:RFP 
under the ida-1 promoter. ALA axons were cut by laser axotomy into multiple 
segments in wild-type worms that either contained (A) or lacked (B) 
mitochondria. 24 hrs after axotomy, the axon segment with a mitochondrion 
was still intact (below), whereas the segment without a mitochondrion had 
degenerated. The mito::RFP images have been inverted and the contrast has 
been enhanced to increase the visibilty of the mitochondria (arrows). Asterisks 
indicate gut autofluorescence. Scale bar = 10 µm. (C) 72% of the axon 
fragments containing a mitochondrion were still present 24 hrs later, whereas 
only 26% of axon fragments without mitochondria perdured. Error bars 
represent the 95% confidence interval (n = 13 worms and 48 axon fragments, 
p= 0.0028, two-tailed Fisher’s Exact Test). (D) A transport chimera construct 
was created by fusing the cDNA for unc-116 (kinesin-1) to the tomm-7 gene, 
which encodes for the outer mitochondrial membrane protein Tom7. GFP 
flanked by linkers was inserted between the motor and the mitochondrial 
protein. The construct was expressed in GABA neurons under the unc-47 
promoter. Below is a conceptual cartoon of the transport chimera protein. (E) 
Expression of the transport chimera ‘Kinesin::Tom7’ restores mitochondria in 
ric-7 mutant axons. See also Figure 2S.4B. (F) The transport chimera 
suppresses the GABA neurotransmission defects in ric-7 mutants. In C. 
elegans, GABA release is required for enteric muscle contractions (emc) 
following posterior body muscle contractions (pboc). In ric-7 mutants, only 16% 
of pbocs are followed by an emc. This defect was rescued by expressing RIC-
7(+) (oxEx1598[RFP::RIC-7]), or the transport chimera ‘Kinesin::Tom7’ in GABA 
neurons. (G) Restoring mitochondria to ric-7 mutant axons (magenta bar) also 
suppressed degeneration of GABA motor neuron axons following injury. The 
transport chimera has no effect in a wild-type background (purple bar). See also 
Figure 2S.4C. The wild-type and ric-7 data are the same as in Figure 2.3G. For 
E-G, p < 0.0001 Kruskal-Wallis test with Dunn’s multiple comparisons to the 













a loss of metabolic support. To test whether mitochondrial metabolism is key for 
axon survival, mutants with electron transport chain defects were assayed for 
degeneration following axotomy. nuo-1 encodes for a subunit of Complex I and 
homozygous mutants arrest at the third larval stage (Tsang, 2001). Mutants 
lacking MEV-1, a subunit of Complex II, are viable as homozygotes but are 
uncoordinated, slow-growing, and have a shortened life-span (Ishii et al., 1998). 
In spite of their mitochondrial dysfunction and health defects, these worms do not 
show an increase in axon degeneration following axotomy; instead, there are 
slightly more axons remaining compared to the wild type (73% and 71%, 
respectively, of axons remain after 24 hrs, Figure 2S.4A). The electron transport 
chain mutants indicate that, (i) mitochondrial dysfunction is insufficient to induce 
axon degeneration on its own and (ii) energy levels are not likely to be the rate-
limiting factor for axon preservation in C. elegans. In humans, nonlethal 
mutations affecting oxidative phosphorylation are rarely associated with 
neurodegeneration, suggesting that impaired mitochondrial bioenergetics do not 
reliably initiate degeneration (Schon and Przedborski, 2011). Additionally, some 
studies suggest that the glycolytic activity of a cell can promote survival during 
impaired oxidative phosphorylation (Calupca et al., 1999; Fünfschilling et al., 
2013; Misko et al., 2012; Tekk k et al., 2003; Winkler et al., 2000). 
 
Restoring mitochondria in ric-7 mutant axons  
suppresses degeneration 
 Even though mutant and wild-type axons lacking mitochondria have 
  
41 
enhanced degeneration, it still remains possible that axon degeneration in ric-7 
mutants is caused by another defect, not noticed in our assays. If mitochondrial 
loss is responsible for the enhanced degeneration, then restoring mitochondria 
into ric-7 deficient axons should suppress axon degeneration. To rescue 
mitochondria localization in ric-7 mutants, we constructed a chimeric transport 
protein that fuses Kinesin-1 (UNC-116) to the outer mitochondrial membrane 
protein Tom7 (encoded by tomm-7) (Kinesin::Tom7, Figure 2.4D). The proteins 
are separated by linkers and GFP. When the chimeric transport protein is 
expressed in GABA neurons, mitochondria are transported into the axons of ric-7 
mutants (Figure 2.4E, 2S.4B). It is also notable that expression of the transport 
chimera also rescues GABA motor neuron function (Figure 2.4F). Restoring 
mitochondria to axons in ric-7 mutants also fully suppresses the degeneration 
phenotype. Axon survival after axotomy is 52% in ric-7 animals in which the 
Kinesin::Tom7 construct is expressed (compared to 58% in the wild type and 0% 
in ric-7, Figure 2.4G, S4C). Expression of the transport chimera does not 
influence degeneration in the wild type. Rescue by forced transport of 
mitochondria in the ric-7 mutant demonstrates that the relevant cause of rapid 




Recent studies suggest contradictory roles for mitochondria in axon 
degeneration. In some cases, mitochondria seem to prevent axon degeneration. 
  
42 
For example, loss of mitochondria caused by knockdown of the kinesin adaptor 
milton lead to degeneration of axons in the fly wing (Fang et al., 2012). Similarly, 
disease-associated alleles of mitofusin-2 in cultured dorsal root ganglia neurons 
disrupted the regular distribution of mitochondria in axons and was associated 
with degeneration (Misko et al., 2012).  
In other cases, mitochondria seem to promote axon degeneration. For 
example, degeneration of neuromuscular junctions is caused by mutations in 
alpha spectrin in flies, and this degeneration is suppressed by mutations in the 
mitochondria transport adaptor miro (Keller et al., 2011). In another example, the 
degeneration of severed axons was prevented by blocking the mitochondrial 
permeability transition pore with the drug cyclosporin A (Barrientos et al., 2011). 
Severed sciatic nerves were cultured in the absence of their neuronal cell bodies, 
thus the drug is acting on mitochondria within the axon to prevent degeneration. 
These studies indicate that mitochondria promote axonal degeneration in both a 
disease model and an injury-based model. 
Our data demonstrate that mitochondria are not a necessary component 
of the degeneration process but rather are required for the protection of axons in 
C. elegans. In ric-7 mutants, mitochondria never migrate into the axons. Some 
axons lacking mitochondria spontaneously degenerate in ric-7 mutants and 
axons that are intact rapidly degenerate after an injury. Other strains with 
disrupted mitochondrial localization, such as animals defective for mitochondrial 
transport (kinesin-1) or mitochondrial division (DRP-1(K40S)), also exhibit rapid 
degeneration after axotomy. Importantly, the absence of mitochondria in wild-
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type axons also causes degeneration, demonstrating that neurodegeneration is 
not due to secondary defects of the mutations, but rather is due to the absence of 
mitochondria. The protective role of mitochondria is underscored by their ability 
to rescue degeneration when they are forced into axons. Hauling mitochondria 
out of cell bodies in ric-7 mutants using a chimeric transport protein 
(Kinesin::Tom7) rescues both neurotransmission and axon degeneration in ric-7 
mutants.  
Perhaps a more nuanced view of mitochondria is warranted; they are 
neither solely protective or destructive but rather seem to play both Jekyll and 
Hyde roles in neurodegeneration. Previous data have demonstrated that 
mitochondria can promote or accelerate degeneration in certain disease states 
(Keller et al., 2011; reviewed in Schon and Przedborski, 2011). Here we show 
that mitochondria are required for axon stability in C. elegans. The absence of 
mitochondria causes rapid degeneration of cut axons in both wild-type and 
mutant axons. These observations suggest two further conclusions: First, 
mitochondria are not required for degeneration. In other words, the swelling, 
beading, and engulfment processes are not directed by mitochondria but must lie 
within the molecular pathways of the axon itself and the surrounding cells. 
Second, mitochondria provide an active, protective role, somehow blocking the 
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Figure 2S.1. Characterization of ric-7. (A) The phylogenetic tree of RIC-7B 
orthologs shows rapid divergence among nematodes. The RIC-7A isoform is 
present only in the Rhabditina clade. RIC-7 from C. elegans and B. malayi only 
share 23% identity; other mitochondrial proteins such as MIRO share 58% 
identity in these species. Orthologs of the RIC-7 isoforms were identified by 
performing BLAST searches of other nematode sequence data and were hand-
assembled from multiple EST and genomic sequences. Sequence identity was 
determined by pairwise BLASTp alignment. (B) ric-7 mutants are defective for 
acetylcholine neurotransmission. Animals become paralyzed when exposed to 
the acetylcholinesterase inhibitor Aldicarb due to accumulation of acetylcholine in 
the synaptic cleft. Paralysis in response to Aldicarb was assayed after 8 hrs. ric-7 
mutants are resistant to Aldicarb, indicating impaired acetylcholine release (n= 
10-20 worms per data point). Similar results have been reported by Hao et al. 
(Hao et al., 2012). (C) In C. elegans, GABA stimulates contraction of the enteric 
muscles (Liu and Thomas, 1994; McIntire et al., 1993a). ric-7 mutants display 
reduced enteric muscle contractions following posterior body muscle 
contractions, and this defect was rescued by expressing RIC-7 (oxEx233) in the 
GABA neurons, ‘RIC-7(+)’. n-values shown in each bar, p<0.01. (D) The active 
zone protein RIM (UNC-10) is normally distributed in the dorsal cord of ric-
7(n2657) mutants. RFP is fused to the PDZ and C2A domains of RIM, which are 
sufficient for proper localization (Otsuga et al., 1998). The number of RIM puncta 
is similar between the wild type and ric-7(n2657) mutants (avg # of RIM puncta 
per 50 µm +/- SEM, 30 and 31 images, respectively, p=0.53 two-tailed t-test). (E) 
A synaptic vesicle marker, the vesicular GABA transporter (vGAT/UNC-47), is 
normally localized in ric-7 mutants. vGAT was tagged with GFP and inserted as a 
single copy. The number of vGAT::GFP puncta is normal in ric-7 mutants (avg # 
of vGAT puncta per 50 µm +/-SEM, 12 and 9 images, respectively, p=0.46 Mann-
Whitney Test). (F) Electron micrographs of neuromuscular junctions in the adult 
ventral nerve cord revealed that ric-7(n2657) has normal numbers of vesicles per 
synapse profile (wild type: 16 synapses, 75 profiles, ric-7(n2657): 15 synapses, 
68 profiles). (G) The active zone protein RIM (UNC-10) is normally distributed in 
the dorsal cord of ric-7(n2657) mutants. (H) A synaptic vesicle marker, the 
vesicular GABA transporter (vGAT/UNC-47), is normally localized in ric-7 
mutants. (I) Dense core vesicles are distributed evenly throughout the axons of 
ric-7 mutants, shown here using the neuropeptide marker FLP-3::Venus. Scale 
bar = 10 µm. (J) Electron micrographs of neuromuscular junctions show synaptic 
vesicles (arrowheads) surrounding the dense projection (*) for the wild type and 
ric-7(n2657). Scale bar = 250 nm. (K) ric-7 is expressed in neurons and head 
muscles. DNA 5 kb upstream of the ric-7a start codon through the second exon 
was fused to a nuclear localization signal (NLS) and GFP (left). Fluorescence 
was observed in most neurons in the head, as well as in the head muscles 
(middle), and motor neurons (right); examples of each are labeled. An asterisk 




















Figure 2S.2. RIC-7 and mitochondria localization. (A) Tagged RIC-7 
(RFP::RIC-7) was made by combining the cDNA for exons 1-10 with the genomic 
sequence for exons 11 through the 3’UTR. The 10th intron was shortened in 
order to remove the coding region for F58E10.7. RFP flanked by linker 
sequences was inserted at the N-terminus. The construct was expressed in 
GABA neurons using the unc-47 promoter. (B) When inserted as a single-copy 
transgene, RFP::RIC-7 is distributed diffusely in the GABA motor neuron cell 
body (arrowhead) and axons. Scale bar = 10 µm. (C) Mitochondria are absent in 
axons of the dorsal nerve cord in ric-7(n2657) mutants. GABA motor neuron 
axons are labeled with soluble RFP and mitochondria in the GABA neurons are 
labelled with mito::GFP. Scale bar = 10 µm. (D) Mito::citrine was expressed in 
the hypodermis under the dpy-7 promoter. Similar structures were observed in 
the wild type and ric-7 mutants. (E) Mito::citrine was expressed in the body wall 
muscles under the myo-3 promoter. Muscle mitochondria form a similar network 



































Figure 2S.3. Axon degeneration is enhanced in the absence of 
mitochondria. (A) The PVQ axon remains intact in the wild type. Scale bar =  
100 µm. (B) HSN axons spontaneously degenerate in ric-7 mutants. Schematic 
of the HSN axon in the wild type and ric-7(zd31) mutants. The HSN cell bodies 
extend a single axonal process to the nerve ring during larval development. (C) 
In a wild-type animal, the HSN axon is continuous and reaches into the nerve 
ring. (D) HSN axons were unaffected in ric-7 young adults, yet degeneration was 
evident in older animals (E). Swelling and distal degeneration was similar to that 
of PVQ. (F) Severed acetylcholine motor neuron axons degenerate in ric-7 
mutants but not wild-type worms. Two acetylcholine (DB) axons were cut per 
animal and reimaged 24 hrs later. The presence or absence of severed axons 
was scored. ***p<0.0001 two-tailed Fisher’s Exact Test. (G) Severed ALA axons 
persist in the wild type but degenerate in ric-7 mutants. Lengths of intact (‘sham’) 
and severed (‘axotomy’) ALA axons 24 hrs after axotomy in wild-type worms and 
ric-7 mutants. Worms with sham axotomies were mounted for surgery but the 
axons were not cut. (p< 0.0001, Kruskal-Wallis Test with Dunn’s multiple 
comparisons ***p<0.001 and **p<0.01 compared to the wild type). (H) ALA axons 
were cut once near the head by laser axotomy in L2 animals and reimaged 24 
hrs later. ALA axons were labelled using the Pacr-5:GAP-43::GFP transgene. In 
these images, the right side was cut in the wild type and the left in the ric-7 worm. 
Arrows mark the ends of the severed axon in the wild type. Arrowheads mark the 
approximate location of the lesion site from the previous day. The cell bodies 
were killed to prevent regeneration, and an asterisk marks the former location of 
the cell body. Scale bar =  100 µm. (I) Overexpression of dominant negative 
DRP-1(K40S) reduces mitochondria in the distal axon and increases 
degeneration of GABA motor neurons. Three axons are visible immediately after 
axotomy. Arrowheads mark the cut sites and arrows indicate some mitochondria 
that have escaped into the distal axon. The worm was moving slightly after the 
surgery. To increase visibility these images were scaled 215% relative to the 24 
hr images, both scale bars are 10 µm. (J) After 24 hrs, only the axon with 
escapee mitochondria is still present. Axon 1 has completely degenerated and 
only two small pieces of debris remain for axon 3. Arrows indicate the location of 
mitochondria in Axon 2. (K) Axons were scored for their presence or absence 24 
hrs after axotomy. In worms overexpressing a dominant negative form of DRP-
1(K40S), only 23% of axons are still present. Of these axons, 70% contain visible 
mitochondria (Average % of axons present 24 hrs after axotomy +/- SEM). p = 
0.0002 two-tailed t-test with Welch correction for unequal variances. The wild-














Figure 2S.4. The transport chimera restores mitochondria to ric-7 axons 
and suppresses degeneration. (A) Impaired mitochondrial function does not 
promote axon degeneration. The electron transport chain mutants mev-1(kn1) 
and nuo-1(ua1) do not have enhanced axon degeneration in spite of their 
mitochondrial dysfunction and impaired health. p = 0.38 one-way ANOVA. The 
wild-type data is the same as in Figure 2.3G. (B) Overexpression of the chimeric 
transport protein Kinesin-Tom7 restores mitochondria out into the axons of ric-7 
mutants. Scale bar = 10 µm. (C) Axons can survive axotomy in ric-7 mutants that 
are expressing Kinesin-Tom7. Two surviving axons can be seen and 
mitochondria are visible in the dorsal nerve cord. In the RFP-only image, a mask 
was created over the gut autofluorescence (grey outline) so that the actual 









Table 2S.1. ric-7 mutations. 
Allele DNA mutation 
(relative to ric-7a cDNA) 
Protein modification 
(relative to RIC-7A) 
Mutagen 
ox134 14.6 kb deletion beginning 
in the 2nd intron 
only amino acids 1-84 
would remain 
ENU 
zd152 c148t R50stop ENU 
n2657 g576a W192stop EMS 
zd31 c634t Q212stop EMS 
nu447  c785t, + 32 base pair 
deletion (nt 865-896) 
A262V, + out of frame 
after C288 and an early 




Supplemental Experimental Procedures 
 
Strains 
Animals were maintained on E. coli OP50-seeded NGM plates according 
to standard methods. See Table 2S.1 for a complete list of strains. See Table 
2S.2 for a complete list of worm strains. 
 
Cloning of ric-7 
Three ric-7 alleles were isolated from three behavioral screens for 
neurotransmission defective mutants: defecation defective, aldicarb resistance 
(Hao et al., 2012), and shrinker behavior, n2657, nu447, and ox134, respectively. 
The ric-7 reference allele n2657 was isolated in a screen for excitatory GABA 
neurotransmission defective mutants. Wild-type hermaphrodites were treated  
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Table 2S.2. Worm strains 
 
 Strain Genotype Transgenes 
n2657 MT6924 ric-7(n2657) V  
ox134 EG2355 ric-7(ox134) V  
nu447 KP7048 ric-7(nu447) V  
zd31 SK31 ric-7/wly-1(zd31) V  
zd152 SK152 ric-7/wly-1(zd152) V  
Pric-7:GFP  EG1702 lin-15(n765ts) X; oxEx174 Pric-7a::NLS:GFP, lin-15(+) 
RIC-7::GFP EG1474 ric-7(n2657) V; lin-15(n765ts) X; 
oxEx233 
Punc-47::RIC-7::GFP, lin-15(+) 
PCR rescue EG2298 ric-7(n2657) V; lin-15(n765ts) X 18kb PCR product, lin-15(+) 
RIM  
wild type 




EG7000 ric-7(n2657) V; lin-15(n765ts) X; 
oxEx1636 
Punc-47:RIM_C2APDZ::RFP, Pmyo-2:GFP,  
lin-15(+) 
vGAT wild type EG5717 unc-119(ed3) III; oxSi36 IV Punc-47:unc-47+GFP(E144), CB unc-119(+) 
vGAT n2657 EG5787 oxSi36 IV; ric-7(n2657) V Punc-47:unc-47+GFP(E144), CB unc-119(+) 
FLP-3  
wild type 




EG6336 ric-7(n2657) V; ceIs61 II Punc-129:flp-3::Venus, Punc-129:mCherry::snb-1, 
Pttx-3:mCherry 






EG5043 lin-15(n765ts) X; oxEx1182 Punc-47:Tom20::GFP, Pmyo-2:GFP, lin-15(+) 
mito::GFP  
n2657 
EG6496 ric-7(n2657) V; lin-15(n765ts) X; 
oxEx1182 
Punc-47:Tom20::GFP, Pmyo-2:GFP, lin-15(+) 
mito::GFP  
ox134 
EG7308 ric-7(ox134) V; lin-15(n765ts) X; 
oxEx1772 
Punc-47:Tom20::GFP, Pmyo-2:GFP, lin-15(+) 
Axon::RFP 
mito::GFP 




EG7161 ric-7(n2657) V; lin-15(n765ts) X; 
oxEx1720 
Punc-47:mCherry, Punc-47:Tom20::GFP, lin-15(+) 
PVQ axon wild type PY1058 oyIs14 V Psra-6::GFP 
PVQ axon zd152 SK5175 ric-7/wly-1(zd152) oyIs14 V Psra-6::GFP 
ALA:GFP wild type EG1399 lin-15(n765ts) X; oxEx81 Pacr-5:GAP43::GFP, lin-15(+) 
ALA:GFP  
n2657 














EG1285 lin-15(n765ts) oxIs12 X Punc-47::GFP, lin-15(+) 
GABA cuts 
n2657 









EG6463 lin-15(n765ts) X; oxEx1541 Pdpy-7:Tom20::citrine, lin-15(+) 
Hypodermis mito 
n2657 
EG6611 ric-7(n2657) V; lin-15(n765ts) X; 
oxEx1541 
Pdpy-7:Tom20::citrine, lin-15(+) 
Muscle mito  
wild type 
EG5515 lin-15(n765ts) X; oxEx1329 Pmyo-3:Tom20::citrine, lin-15(+) 
Muscle mito n2657 EG6859 ric-7(n2657) V; lin-15(n765ts) X; 
oxEx1329 
Pmyo-3:Tom20::citrine, lin-15(+) 
HSN ric-7(zd31) SK5249 zdIs13 IV; ric-7/wly-1(zd31) V tph-1::gfp 
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Table 2S.2. continued 
 Strain Genotype Transgenes 
kinesin-1 
mito::GFP 
EG6615 unc-116(rh24sb79) III; oxEx1182 Punc-47:Tom20::GFP, Pmyo-2:GFP, lin-15(+) 
kinesin-3 
mito::GFP 
EG8300 unc-104(e1265) II; oxEx1182 Punc-47:Tom20::GFP, Pmyo-2:GFP, lin-15(+) 
kinesin-1 
axotomy 
MJB1280 unc-116(rh24sb79) III; oxIs12 X Punc-47::GFP, lin-15(+) 
kinesin-3 
axotomy 
MJB1281 unc-104(e1265) II; oxIs12 X Punc-47::GFP, lin-15(+) 
DRP-1(K40S) EG8125 oxIs12 X; oxEx1974 Punc-47:DRP-1(K40S), Punc-47:Tom20::mCherry, 
Pmyo-2::mCherry, lin-15(+) 
Kinesin::Tom7 EG8301 oxIs12 X; oxEx1973 Punc-47::unc-116_GFP::tomm-7, Punc-
47::Tom20::mCherry, Pmyo-2::mCherry, lin-15(+) 
Kinesin::Tom7 
ric-7(n2657) 
EG8124 ric-7(n2657) V; lin-15(n765ts) 
oxIs12 X; oxEx1973 
Punc-47::unc-116_GFP::tomm-7, Punc-
47::Tom20::mCherry, Pmyo-2::mCherry, lin-15(+) 
mev-1 EG8302 mev-1(kn1) III; oxIs12 X Punc-47::GFP, lin-15(+) 
nuo-1 EG8303 nuo-1(ua1)/mIn1[dpy-10(e128) 




















with ethyl methanesulfonate (EMS), and F2 progeny were screened for animals 
exhibiting a constipated phenotype. Two alleles (zd31, zd152) were recovered 
from a screen for mutants with defects in growth or morphology of the PVQ 
axons (see Clark and Chiu, 2003 for details). In brief, sra-6::gfp(oyIs14) animals 
were treated with EMS or N-ethyl-N-nitrosourea (ENU), and F2 progeny that 
exhibited behavioral defects were picked. F3 progeny were then examined using 
epifluorescence microscopy to find mutants with PVQ axonal defects. The alleles 
zd31 and zd152 exhibited discontinuous blebbing and truncation of the PVQ 
axons and the gene was named wly-1 (wallerian-like decay). wly-1 and ric-7 were 
independently cloned and later established to be the same gene. Because the 
gene name ric-7 is published, we use the name ric-7 as well. 
The reference allele n2657 was mapped between lin-25 and unc-76 on 
chromosome V. Three-factor mapping placed ric-7 to the left of him-5 (Figure 
2.1A). Cosmid F58E10 rescued the Aldicarb-resistance phenotype of ric-7 
mutants by germline transformation. F58E10 contains 11 predicted genes. Using 
PCR and germline rescue experiments, we localized the rescuing activity of 
F58E10 to an 18 kilobase fragment that contains two hypothetical genes, 
F58E10.1 and F58E10.7 (Figure 2.1A). A similar series of mapping and rescue 
experiments identified F58E10.1 as the gene wly-1. To ascertain which of the two 
candidate genes represents ric-7/wly-1, we identified the molecular lesions 
associated with the five mutant alleles. All alleles contain mutations in F58E10.1 
exons (Figure 2.1B). Mutations are summarized in Table 2S.1. 
Gene structure and protein. The ric-7 coding region is contained in 13 
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exons dispersed over 15 kb (WBGene00010259, www.wormbase.org). We 
sequenced the full-length ric-7 cDNA clone yk14h10 (gift from Yuji Kohara, 
Japan) to confirm the predicted gene structure. The ric-7 cDNA contains 2085 
bases of coding sequence, 86 bp of 5’ UTR and 378 bp of 3’ UTR. Analysis of 
ric-7 cDNAs indicates that ric-7 encodes two splice forms that differ in their first 
exon: RIC-7A (694 aa) and RIC-7B (709 aa).   
To investigate the function of RIC-7, we sought possible homologous 
sequences. Blast searches of the full-length protein with sequence databases 
failed to identify homologs in species outside of nematodes. Even within 
nematodes, RIC-7 sequences appear to have diverged rapidly (Figure 2S.1A). 
The RIC-7 amino acid sequence does not contain any obvious protein domains.   
Gene expression analysis indicates that ric-7a is expressed primarily in 
neurons and a few muscles. We generated a reporter containing genomic 
sequence from 5 kb upstream of the ric-7a ATG through to the second exon 
fused to a nuclear localization signal (NLS) and GFP. GFP was detected 
primarily in neurons as well as in the head muscle cells (Figure 2S.3A). Despite 
the presence of an NLS, GFP expression appears to be cytosolic. 
 
Molecular biology 
Most plasmids were made using the Invitrogen multisite Gateway cloning 
technique. We created the mitochondrial marker by fusing GFP to the 
mitochondrial targeting sequence (first 54 amino acids) of the translocase of 
outer mitochondrial membrane (Tom20, encoded by tomm-20) (Watanabe et al., 
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2011). RIM localization was determined by fusing RFP to the C2A and PDZ 
domains of UNC-10. These two domains are sufficient to localize the RIM 
fragment to the dense projection (Deken, 2005). The synaptic vesicle marker was 
constructed by inserting GFP between E144 and N145 of UNC-47. The construct 
was inserted into the worm genome as a single copy using the MosSCI 
technique (Frøkjær-Jensen et al., 2008). The ALA:GFP transgene (oxEx81) 
encodes a membrane-bound GFP (40 aa myristoylation sequence of 
GAP43::GFP) and is expressed under the acr-5 promoter (Knobel et al., 2001). 
oxIs609 was generated by X-ray integration of oxEx81. 
The constructs for tagging RIC-7 with RFP were made by combining the 
cDNA for exons 1-10 (Gateway [1-2] vector) with the genomic sequence for 
exons 11 through the 3’UTR (Gateway [2-3] vector). The third recombination site 
attB2 is embedded within the 10th intron, which was shortened to remove the 
coding region for F58E10.7. This hybrid construct expressed under the unc-47 
promoter rescued mitochondrial distribution in the GABA motor neurons. RFP 
flanked by linker sequences was inserted into the base constructs at five different 
locations; N-terminus, C-terminus, H104, E332, and Q440. All three internal tags 
yielded modest to poor rescue of mitochondrial distribution. The N-terminal tag 
was the only transgene that was visible when integrated at single copy. The A 
splice form was used because it provided better rescue of the mitochondrial 
localization defect than the B form did (data not shown). 
The mitochondria transport chimera construct (Kinesin-Tom7) contains the 
following elements in order from 5’ to 3’: the unc-47 promoter (1,254 bp), the 
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cDNA for unc-116 (2,448 bp), linker sequence (36 bp), GFP with syntrons (864 
bp), att recombination site + 2nd linker (63 bp), the genomic sequence of tomm-7 
(437 bp), and the let-858 3’ UTR (439 bp). The unc-116 cDNA through GFP are 




 In C. elegans, defecation is a programmed behavior that occurs every 45-
50 seconds. The defecation cycle is initiated by a posterior body wall muscle 
contraction (pBoc) and completed with an enteric muscle contraction (Emc). The 
Emc requires nervous system function and the excitatory action of the 
neurotransmitter GABA (Liu and Thomas, 1994; McIntire et al., 1993a, 1993b). 
The defecation cycle of young adults from each strain were scored as described 
previously (Thomas, 2002). Briefly, the number of pBocs followed by an Emc 
were quantified. For Figure 2.4F, each worm was assayed for at least 6 cycles. 
 Aldicarb sensitivity was assayed as previously described (Nguyen et al., 
1995). Unless otherwise stated, Aldicarb was added to NGM plates at the final 
concentrations: 0.01, 0.02, 0.04, 0.09, 0.18, 0.35, 0.70, 1.4 mM. Ten to 20 young 
adults from each strain were placed on a plate at each Aldicarb concentration, 







 Adult nematodes were prepared for transmission electron microscopy as 
previously described (Jorgensen et al., 1995). Specimens were fixed in 0.8% 
glutaraldehyde, 0.7% osmium tetroxide in 0.1 M cacodylate for 2 hrs and then 
washed in buffer. Next, the animals’ heads and tails were removed, the tissue 
postfixed in 2% osmium tetroxide in 0.1 M cacodylate overnight at 4°C, then 
washed extensively in water. 117 specimens were then stained en bloc in 1% 
uranyl acetate, dehydrated with ethanol, passed through propylene oxide, and 
embedded in epoxy resin. Ribbons of ultrathin (~33 nm) sections were imaged. 
 
Imaging 
Worms were immobilized in either 10 mM muscimol or 25 mM sodium 
azide on 3% agarose pads. Images were acquired on a Pascal LSM5 confocal 
microscope (Zeiss) with a 63x 1.4NA oil objective. Dorsal and ventral cord 
images were taken with the cord facing toward the objective. Three Z-stacks 
were acquired from each worm, 16.81 µm by 96.84 µm with a 1.5 zoom factor. 
The total number of fluorescent puncta was quantified from maximum intensity 
projections using the Cell Counter ImageJ plugin. Images were blinded by 
assigning each a random 5-digit number generated in Excel. The data are 
presented as the average number of puncta per 50 µm. 
 Images of the RFP::RIC-7 single copy insert (Figure 2S.2B) were acquired 
using a Nikon spinning disc confocal with a Photometrics Cascade II EMCCD 
camera, generously made available by the laboratory of V. Maricq. A single focal 
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plane was imaged with a 300 ms exposure time. The signal is very dim, so 20 
frames were averaged to enhance the signal-to-noise ratio. 
 
Laser axotomy 
 L2 worms were immobilized as described above. Axons containing GFP 
were cut using 1) a pulsing 810 nm light from a Ti:Sapphire laser (Mira900, 
Coherent) assembled on a LSM510 Meta confocal microscope (Zeiss) and 
focused through a 63x 1.4NA objective or 2) a pulsing 355 nm laser (FTSS355-
Q3, CryLaS GmbH, Germany) assembled on a Nikon D-Eclipse C1, 90i confocal 
microscope with a Nikon 40x 1.3NA objective. The ALA neuron has a single cell 
body in the head of the worm (dorsal to the posterior bulb of the pharynx) and 
extends two axons along the length of the worm at the right and left midline. In all 
experiments, either the right or left axon was cut and the same side of the worm 
was imaged on the following day. After the axons were cut, the laser was used to 
kill the cell bodies, which would otherwise regenerate new axons that obscure 
the degeneration analysis. Images were acquired immediately after cutting. 
Worms were then recovered from the agarose pad and placed on bacterial NGM 
plates for 24 +/- 4 hrs. Images were acquired on the Pascal confocal (Zeiss) on 
the following day. For the ric-7 experiments (Figure 2.5A,B), the ALA axon was 
cut once in the anterior of the worm behind the head, and then the cell body was 
killed. Images from the following day were analyzed in ImageJ by tracing the 
axon segment to measure its length.  
For the wild-type experiments (Figure 2.5D-F), the ALA axon was cut into 
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multiple pieces proceeding anterior to posterior, and then the cell body was 
killed. The most anterior and posterior axon pieces were not included in the 
analysis, since the head and tail ganglia make it impossible to determine the 
presence or absence of mitochondria in these segments. On average, there were 
four axon segments per worm, and 61% of segments contained at least one 
mitochondrion. For each worm, the images from both days were compared side-
by-side to determine which segments were still present. Each segment was also 
scored for the presence or absence of mitochondria at both time points. 
 The GABA and acetylcholine motor neuron commissures were cut once 
just below the midline of the worm. The cell bodies were then killed to prevent 
regeneration. Four to five VD/DD or two DB commissures were cut per worm; the 
transgenes oxIs12 and oxEx81 were used, respectively. The worms were imaged 
again 24 hrs later and the number of commissures still present was quantified. 
The GFP in the GABA motor neuron experiments is soluble and on occasion 
would leak out of the commissures immediately following the injury. Images were 
acquired postaxotomy and only commissures that were still visible were included 
in the 24 hr analysis. 
 
Statistics 
In most cases, nonparametric tests were used; the Kruskal-Wallis for 
multiple comparisons and the Fisher’s Exact test for two-sample data sets. The 
data sets did not meet the requirements for parametric tests for the following 
reasons. The mitochondria distribution and enteric muscle contraction data sets 
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did not pass the equal variance test. The degeneration data sets are not normally 
distributed because the ric-7 data are consistently at zero. All statistics were 
performed with the GraphPad InStat software. 
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ENGULFMENT OF AXONAL DEBRIS BY EPITHELIAL  
CELLS REQUIRES CED-1 AND CED-6 BUT NOT  





Axon degeneration occurs in response to disease and injury. After an axon is 
detached from the cell body, it fragments into small pieces, which are then engulfed by 
other cells. We are studying axon degeneration using a genetic neurodegeneration 
model, as well as laser axotomy of wild-type axons. In beta-spectrin/unc-70 mutants, 
axons break spontaneously and the portion of the axon distal to the break degenerates. 
We have examined the role of apoptosis genes in the break down and removal of 
degenerating axons in C. elegans. Two parallel engulfment pathways act to remove cell 
corpses after apoptosis: ced-1, -6, -7 and ced-2, -5, -12. Both ced-1 and ced-6 are 
required for the engulfment of axonal debris in C. elegans. However, ced-7 was only 
involved in removing debris during neurodegeneration in beta-spectrin mutants. None of 
the members of the ced-2, -5, -12 pathway nor ced-10 are required for axonal debris 
removal. Thus, the engulfment of axonal debris in C. elegans requires only one of the 





 Axon degeneration occurs in neurodegenerative diseases, in response to injury, 
and during developmental pruning (Luo and O’Leary, 2005). While generally considered 
deleterious, degeneration can actually play beneficial roles in neuronal health. 
Developmental pruning is essential for an optimally functioning nervous system (Luo 
and O’Leary, 2005), and the removal of damaged axons is advantageous for recovery 
(Hosmane et al., 2012; Tanaka et al., 2009).  
 In recent years, multiple studies have identified roles for the apoptosis pathway in 
breaking down and clearing axons. The apoptosis pathway was originally identified in C. 
elegans for its role in programmed cell death and subsequent cell corpse removal 
during embryogenesis (Ellis and Horvitz, 1986; Hedgecock et al., 1983). The apoptosis 
pathway consists of multiple phases, including the killing phase and the engulfment 
phase. During the killing phase, CED-4 is released from CED-9 and activates the 
caspase CED-3, which then initiates the process of destroying the cell (Conradt, 2009; 
Conradt and Horvitz, 1998; Ellis and Horvitz, 1986). Once the cell has died, the corpse 
is cleared away by other cells through engulfment. There are two parallel pathways 
involved in cell corpse engulfment; the CED-1, -6, -7 pathway and the CED-2, -5, -12 
pathway (Mangahas and Zhou, 2005; Reddien and Horvitz, 2004). 
 The CED-1, -6, -7 pathway is involved in cell corpse recognition. The ABC 
transporter CED-7 is required in both the corpse and the engulfing cell and is 
responsible for displaying the phosphatidylserine (PS) ‘eat me’ signal on the surface of 
the cell corpse (Hamon et al., 2000; Mapes et al., 2012; Wu and Horvitz, 1998a). CED-1 
is a phagocytic receptor located on the surface of the engulfing cell. CED-1 recognizes 
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the ‘eat me’ signal and recruits the engulfing cell to the surface of the cell corpse (Zhou 
et al., 2001a). CED-6/GULP is a PTB domain protein that interacts with the intracellular 
portion of CED-1 and is believed to transduce the phagocytosis signal from the cell 
membrane to cytoplasmic machinery (Liu and Hengartner, 1998; Su et al., 2002). 
 The CED-2, -5, -12 engulfment pathway is involved in regulating the cytoskeleton 
within the engulfing cell. CED-2/CrkII, CED-5/DOCK180, and CED-12/ELMO form a 
complex that serves as a guanine exchange factor (GEF) to activate the Rac GTPase 
CED-10 (Brugnera et al., 2002; Gumienny et al., 2001; Reddien and Horvitz, 2000; Wu 
et al., 2001; Zhou et al., 2001b). Rac is then responsible for rearranging the 
cytoskeleton to engulf the corpse (Mangahas and Zhou, 2005; Zhou et al., 2001b). 
 Components of both the killing and engulfment pathways have been implicated in 
the breakdown of axons and dendrites. Drosophila studies on axon pruning and injury-
induced dendritic degeneration did not find a role for caspases in neurite destruction 
(Awasaki et al., 2006; Tao and Rolls, 2011). However, multiple other studies have 
suggested that caspases and their up- and down-stream regulators are involved in the 
pruning of dendrites. Dronc is an apoptotic Nedd-2-like initiator caspase that interacts 
with the fly homolog of CED-4, Dark (Dorstyn et al., 1999; Quinn et al., 2000). Dronc 
has been shown to mediate dendritic pruning of the ddaC and Cd4a sensory neurons 
(Kuo et al., 2006; Schoenmann et al., 2010; Tao and Rolls, 2011; Williams et al., 2006). 
Effector caspases of Dronc have also been implicated in dendritic pruning via 
experiments with effector caspase inhibitors and cleavage products (Williams et al., 
2006).  
Caspases and other members of the killing pathway are also active during axon 
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degeneration. One Dronc effector caspase candidate is Dcp1/caspase-6. Caspase-6 
has been shown to mediate axon degeneration in mammalian cells along with Bax 
(Nikolaev et al., 2009; Schoenmann et al., 2010), and more recently, Dcp1 has been 
shown to promote the degeneration of neuromuscular junctions in fly ankyrin2 mutants, 
along with Dark/CED-4 and the Bcl2-homolog Debcl (Keller et al., 2011).   
 Studies in Drosophila have additionally shown that the apoptosis engulfment 
pathways are involved in the removal of degenerating axons. CED-1/Draper and CED-6 
are required for axon engulfment following both axotomy and developmental pruning 
(Awasaki et al., 2006; Macdonald et al., 2006; Williams et al., 2006). More recently, the 
CED-2, -5, -12 pathway has also been shown to mediate the engulfment of 
degenerating axons following axotomy (Ziegenfuss et al., 2012). Ziegenfuss et al. 
demonstrate that CED-1/Draper is essential for the recruitment of glia to injured neurons 
and that the CED-2, -5, -12 pathway is required for their internalization. 
 Here we examine the role of the engulfment pathways in both genetically- and 
injury-induced axon degeneration in C. elegans. Mutations in spectrin result in 
neurodegeneration in animal models and spastic paraplegia in humans (Ikeda et al., 
2006; Massaro et al., 2009; Parkinson et al., 2001). In C. elegans beta-spectrin/unc-70 
mutants, axons break due to movement (Hammarlund et al., 2007). The distal, 
detached portion of the axon undergoes degeneration while the proximal axon will 
generate a growth cone and extend a new axon. The new axons are eventually broken 
and the cycle repeats itself, resulting in animals that are continually undergoing axon 
degeneration. We examined the role of caspases and the engulfment pathways in axon 




The ced-1, -6, -7 pathway is required for engulfment  
of axonal debris in unc-70 
 In beta-spectrin null mutants, unc-70(s1502), axons spontaneously break and are 
continually undergoing axon degeneration and regeneration (Hammarlund et al., 2007). 
This is an ideal model in which to study the process of axon degeneration; degeneration 
can be observed at any time point without the need for invasive experimental 
procedures. Animals are expressing soluble GFP in the GABA neurons under the unc-
47/vGAT promoter, oxIs12[Punc-47::GFP]. The degenerating GABA motor neuron 
axons in beta-spectrin mutants undergo morphological changes similar to those 
described by Augustus Waller, known as Wallerian degeneration. After a break occurs, 
the axon first blebs, turning into a string of beads, the beads eventually become isolated 
particles of debris that are then cleared away by neighboring cells (Hammarlund et al., 
2007).  
 Beta-spectrin animals examined at the fourth larval stage (L4) display large 
detached segments of axons (average of 2.3 +/- 0.3, N=46; 0 in wild-type worms) as 
well as considerable amounts of axon debris particles (on average 16.4 debris particles 
per worm +/- 1.4, N=56, compared to 2.3 +/- 0.5, N=10 in the wild type). Mutations in 
genes required for clearing away dead cells are predicted to result in an increase in 
axonal debris in beta-spectrin mutants. Mutations for engulfment pathway members 
ced-1(e1735), ced-6(n1813), and ced-7(n1996) were crossed into the beta-spectrin 
mutants. All three of these alleles displayed a significant increase in the amount of 











Figure 3.1. ced-1, ced-6, and ced-7 are required for the clearance of 
axonal debris in beta-spectrin mutants. (A) The GABA motor neuron 
axons in beta-spectrin/unc-70 mutants break during movement and are 
undergoing a continuous cycle of regeneration and degeneration. Broken 
axons undergo fragmentation and clearance. In L4 beta-spectrin null 
mutants, pieces of axonal debris can be seen (dashed circle). Axonal debris 
is accumulated in worms that are also carrying mutations for ced-1, ced-6, or 
ced-7. All worms are unc-70(s1502) and expressing soluble GFP in the 
GABA motor neurons under the unc-47 promoter (oxIs12). (B) The average 
number of debris pieces per worm + SEM. N= total number of worms. p < 
0.0001 Kruskal-Wallis test with Dunn’s multiple comparisons, *** p < 0.001, 
**p < 0.01 compared to unc-70 alone (gray bar). 
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7(n1996) are null alleles. ced-6(n1813) is a loss-of-function allele and had the smallest 
increase in axonal debris of the three alleles. 
 
The ced-2, -5, -12 pathway is not required for engulfment  
of axonal debris in beta-spectrin mutants 
 Engulfment of cell corpses is carried out by two parallel pathways. To determine 
whether the second engulfment pathway is also involved in clearing axonal debris, we 
crossed null mutations for ced-2(e1752), ced-5(n1812), and ced-12(k149) into beta-
spectrin mutants. Unlike the ced-1 pathway, these mutations did not result in an 
increase in axonal debris. Alleles for all three mutations contained an amount of axonal 
debris similar to that of unc-70 alone (average debris pieces per worm are 20.5, 20.1, 
and 15.4, respectively. n.s., p = 0.38 One-way ANOVA). 
 It is possible that the ced-2 engulfment pathway is contributing a minor role to the 
engulfment of axon debris that cannot be easily revealed in beta-spectrin mutants. To 
ensure that this pathway is not contributing to engulfment, we tested whether there is an 
additive effect for removing ced-5 in a ced-1 background. In cell corpse removal, 
mutations in the ced-2, -5, -12 engulfment pathway can enhance the impairment seen in 
ced-1 mutants, as is typical for mutations in parallel pathways. However, ced-5 did not 
enhance the amount of axon debris observed in ced-1; unc-70 animals (49.3 vs. 46.4 
average debris pieces per worm, respectively. Figure 3.2 C,D). This further 
demonstrates that the ced-2, -5, -12 pathway is not functioning in the clearance of 











Figure 3.2. The ced-2, -5, -12 engulfment pathway is not required for the 
clearance of degenerating axons in C. elegans. (A) Axonal debris pieces 
are not accumulated in beta-spectrin/unc-70 mutants that are carrying 
mutations for ced-2, ced-5, or ced-12. (B) Average number of debris pieces 
per worm + SEM. n.s., p = 0.38 One-way ANOVA. N= total number of 
worms. The beta-spectrin data (gray bar) are the same as in Figure 3.1B. (C) 
ced-5 does not have an additive effect on ced-1 for the clearance of 
degenerating axons. (D) The average number of debris pieces per worm is 
unchanged between ced-1 and ced-1; ced-5 double mutants. The beta-
spectrin data (gray bar) and the ced-1 data (blue bar) are the same as in 





The core apoptosis pathway is modestly involved  
in axonal degeneration 
 We questioned whether the killing phase of the cell death pathway is involved in 
fragmenting broken axons. To investigate this possibility, null beta-spectrin mutants 
were crossed into strong-loss-of-function mutations for ced-3(n717) and ced-4(n1162), 
and a gain of function mutation in ced-9(n1950dm), which has an antiapoptotic function. 
To assay fragmentation in beta-spectrin mutants, we measured the portion of the dorsal 
side of the worm that is covered with continuous sections of axons. In a wild-type worm, 
the coverage is close to 100%, whereas only around 40% of the dorsal nerve cord is 
present in a beta-spectrin mutant. If removing the apoptotic caspase pathway 
decreases degeneration, there should be an increase in the dorsal cord coverage as 
broken axons should perdure and accumulate. However, mutations in the core apoptotic 
pathway did not alter dorsal cord coverage, suggesting degeneration was unaffected 
(Figure 3S.1A,B). It is possible that engulfment may be able to override the 
fragmentation process. In other words, axon pieces may be engulfed and cleared away 
even in the absence of efficient fragmentation. To impair engulfment, ced-1(e1735) was 
crossed into each strain. In ced-1, apoptosis double mutants, we observed a significant 
increase in the amount of dorsal nerve cord coverage compared to ced-1 alone (Figure 
3.3, p= 0.0016 one-way ANOVA). ced-1; ced-3 double mutants had the greatest amount 
of axon preservation (57% dorsal cord coverage compared to 30% for ced-1, p< 0.001 
Tukey-Kramer Multiple comparisons), whereas ced-1; ced-4 and ced-1; ced-9 double 
mutants only had a modest increase in dorsal nerve cord coverage (Figure 3.3B). This 
suggests that the caspase ced-3 is involved in axon fragmentation in beta-spectrin  
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mutants. 
 There are several points of caution to this result. Firstly, as mentioned above, the 
caspase pathway does not alter the dorsal cord coverage in the absence of the ced-
1(e1735) mutation (Figure 3S.1A,B). However, cooperativity between the engulfment 
and the cell killing pathways has been repeatedly demonstrated (Galvin et al., 2008; 
Hoeppner et al., 2001; Li and Baker, 2007; Neher et al., 2011; Neukomm et al., 2011; 
Reddien et al., 2001). Thus, a functioning ced-1 pathway could be promoting 
fragmentation even in the absence of ced-3. Secondly, if the caspase pathway is 
Figure 3.3. The caspase ced-3 is required for axon degeneration in beta-
spectrin mutants. (A) In wild-type animals, nearly 100% of the dorsal cord contains 
GABA motor neuron axons. In beta-spectrin/unc-70 mutants, only 42% of the dorsal 
cord is covered in axons and 30% is covered in ced-1(e1735); unc-70(s1502) 
mutants. Crossing in mutants for the killing phase of the apoptosis pathway 
augments the dorsal nerve cord coverage, suggesting that there is greater axon 
preservation. The yellow lines illustrate the sections of the dorsal cord that are 
covered with axons. (B) For each worm, the distances of axon coverage were 
measured, summed, and divided by the length of the worm. The average % of dorsal 
cord + SEM are shown. ced-4(n1162) and the gain-of-function (gf) mutation ced-
9(n1950dm) modestly increased dorsal cord coverage. The loss of function mutation 
in the caspase ced-3(n717) significantly increased the dorsal cord coverage in ced-1; 
unc-70 worms (p= 0.0002 One-way ANOVA with Dunnett’s multiple comparisons to 




required for fragmentation, then the amount of large axon segments should increase 
while the amount of debris should diminish. There is no change in the number of large 
axon segments (Figure 3S.1C) and only ced-9(gf) has significantly less debris, although 
ced-3 also shows a decrease (Figure 3S.1D). Lastly, the increase in the dorsal nerve 
cord coverage could be due to an enhancement in regeneration, which might explain 
the significantly greater number of commissures in the ced-1; ced-3 double mutants 
(Figure 3S.1E). This, however, is unlikely to be the case as the Driscoll lab has recently 
shown that ced-3 and ced-4 are required for regeneration (Pinan-Lucarre et al., 2012). 
An impairment in regeneration could explain why there is not a stronger result for this 
pathway during degeneration. The degeneration assay is dependent upon robust 
regeneration to continually provide degenerating axons. If these mutants have 
decreased regeneration, it may be challenging to detect an accumulation of intact but 
broken axons. 
  
In wild-type worms, ced-1 and ced-6 are required  
for engulfment of axonal debris 
 To determine whether the engulfment pathways are involved in axon 
degeneration independent of the beta-spectrin mutation, we performed laser axotomy 
on wild-type worms and ced mutants. Axon degeneration is limited in wild-type C. 
elegans (Chapter 2; Pinan-Lucarre et al., 2012; Wu et al., 2007). Axons cut in larval 
stage 4 (L4) worms do not degenerate and can persist for at least 8 days (data not 
shown). However, if axons are cut in young worms, larval stage 2 (L2), degeneration is 
observed. Axon regeneration in C. elegans is also age-dependent (Hammarlund et al., 
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2009; Nix et al., 2011; Wu et al., 2007). We performed axotomy on the ALA neuron in 
L2 worms expressing membrane-bound GFP under the acr-5 promoter, oxEx81[Pacr-
5::GAP4340aa::GFP] (Figure 3.4). After axotomy, the worms are recovered to standard 
worm maintenance conditions for 24 hrs, reimaged, and assayed for degeneration. The 
ALA axon originates in the head and projects to the tail of the worm along the lateral 
midline (Figure 3.4A). When this long axon is cut into multiple pieces, nearly half of the 
pieces (45% +/- 4.3%, N=26) will degenerate in a wild-type worm (Figure 3.4B, C).   
 In wild-type worms, ALA axon degeneration is complete within 24 hrs and axonal 
debris is rarely present. By contrast, axonal debris is accumulated in both ced-1 and 
ced-6 mutants (Figure 3.5, p< 0.0001 Kruskal-Wallis Test). Two loss of function alleles 
were tested for ced-6. While ced-1(e1735) has 23-fold greater debris than the wild type, 
ced-6(n2095) and ced-6(n1813) have 12-fold and nearly 5-fold greater amounts of 
debris, respectively. The data are expressed as the average amount of debris per 100 
µm in order to control for any variability in worm size. Because only some of the axon 
pieces degenerate, the axon debris tends to be clustered (dashed circles, Figure 3.5A) 
rather than evenly distributed across the worm. The number of large axon pieces was 
not increased in any of the mutants (Figure 3S.2A). Surprisingly, we did not observe an 
involvement for ced-7 in axon debris clearance after injury of healthy axons. Neither of 
the null mutations ced-7(1996) or ced-7(n1892) lead to an accumulation of axonal 
debris following axotomy of the ALA axon (Figure 3.5B,C). 
 We additionally tested ced-1 mutants for engulfment after axotomy of the GABA 













Figure 3.4. Axon degeneration following laser axotomy of the ALA axon. (A) 
Schematic of the laser axotomy procedure for ALA axons. The ALA neuron is in 
the dorsal head of the worm and extends an axon along the lateral midline of the 
worm. The axon is first severed at the anterior of the worm. Second, multiple cuts 
are made along the axon moving anterior to posterior. Third, the ALA cell body is 
killed with the laser to prevent axon regeneration from occurring and obscuring 
the degenerating axons. (B) Images of an L2 worm immediately preceding and 
following laser axotomy. Worms are expressing Pacr-5::GAP4340aa::GFP 
(oxEx81), which is a membrane-bound GFP expressing in the ALA neuron, head 
and tail ganglia neurons, and the DB motor neurons. The ALA axon was severed 
into 6 pieces (excluding the most anterior and posterior segments which are 
largely concealed by the head and tail ganglia). The location of the cut sites are 
marked with arrows and the axon segments are numbered. (C) After a 24 hr 
recovery period, the worm was imaged again. There are three axon segments 
remaining (arrowheads) and the rest of the axon has degenerated. On average 
45% (+/- 4.3%, N= 26 worms) of the axons segments degenerated. In a wild-type 
worm, the degenerating axons are completely cleared away within 24 hrs and 
debris remnants of axons are rarely seen. (D) The ALA axon runs down the 
midsection of an uninjured L4 worm. The dotted yellow line marks where the 
dorsal nerve cord is out of the focal plane. (E) A magnified view of the region 
outlined by a red box in panel C. Two of the axon segments that did not 
degenerate are marked with arrowheads. The asterisk indicates autofluorescence 
from the gut. (F) An expanded view of the region within the red box in panel D. 
The uninjured ALA axon can be seen at the midpoint between the dorsal and 






greater amounts of debris from severed commissures compared to the wild type (3.5 +/- 
0.9 vs. 0.4 +/- 0.3, p= 0.0036 two-tailed Mann-Whitney test). Thus, ced-1 and ced-6 are 
required for the engulfment of axonal debris in response to both a neurodegenerative 
disorder and an injury.  
 Similar to the beta-spectrin data, there was no increase in axonal debris in ced-2 
or ced-5 mutants following axotomy of the ALA axon. This further demonstrates that 
Figure 3.5. ced-1 and ced-6 are required for engulfing axonal debris after 
injury. (A) In wild-type worms, axonal debris is rarely observed 24 hrs after 
axotomy of the ALA axon. However, in ced-1 and ced-6 mutants, axonal debris 
remains uncleared after one day. The dashed white circles highlight clusters of 
perduring axonal debris. The dotted yellow line marks where the out of focus 
dorsal nerve cord would be. The asterisk indicates autofluorescence from the gut, 
which is dimmer and more uniform in size compared to the axonal debris. (B) 
ced-7 and ced-5 are not required for the engulfment of degenerating ALA axons 
after axotomy. Pieces of axonal debris are only rarely observed (dashed circles). 
(C) ced-1 and two alleles of ced-6 have significantly greater amounts of axonal 
debris compared to the wild type (average # of debris pieces per 100 µm + SEM, 
p< 0.0001 Kruskal-Wallis Test, *** p<0.001, **p<0.01 Dunn’s multiple 
comparisons test compared to the wild type). Contrary to the beta-spectrin 
mutant results, ced-7 is not required for clearing away severed axons in a wild-
type background. ced-2, ced-5, and ced-10 are not involved in clearing axonal 
debris in C. elegans. N= total number of worms 
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only one of the engulfment pathways is involved in the removal of axonal debris in C. 
elegans. Classically, the Rac GTPase ced-10 is thought to be downstream of the ced-2, 
-5, -12 pathway. However, recent work has shown that the two engulfment pathways 
can converge onto ced-10 (Kinchen et al., 2005; Ziegenfuss et al., 2012). If this is true, 
we would expect to see an involvement of ced-10 in axon debris removal in C. elegans 
even though the ced-2, -5, -12 pathway is not active. Null alleles of ced-10 are lethal so 
we performed laser axotomy of ALA in the strong hypomorphic allele ced-10(n3246). 
The n3246 allele has a mutated GTP binding site and has been shown to have 
significant impairments in cell corpse engulfment in developing embryos (Kinchen et al., 
2005; Reddien and Horvitz, 2000). However, this mutation did not exhibit any 
impairments in axonal debris clearance, indicating that in C. elegans axon 
degeneration, ced-10 is not acting downstream of the ced-1 engulfment pathway 
(Figure 3.5C).   
 
Hypodermal cells engulf axon debris in C. elegans 
 To determine which cell type is engulfing axon debris in C. elegans, we 
conducted cell-specific rescue experiments for ced-1. In vertebrates, the engulfing cell 
is typically macrophages or glial cells (Sokolowski and Mandell, 2011). However, the C. 
elegans glial sheath cells are only found in the head and tail of the worm. Instead, 
axons are in close proximity to the hypodermis and neighboring neurons. ced-1 cDNA 
was expressed in neurons (Prab-3), the hypodermis (Pdpy-7), or all cells (Peft-3) and 
inserted into the genome as a single copy using the mosSCI technique (Frøkjær-Jensen 
et al., 2008). Each of the transgenes was crossed into the ced-1(e1735); oxEx81 strain. 
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Rescue of developmental cell corpse engulfment was assessed to confirm that the ced-
1 construct was functional. C. elegans embryos have an accumulation of apoptotic cell 
corpses in ced-1 mutants, which can be rescued by expressing ced-1 under its 
endogenous promoter (Zhou et al., 2001a). Both the ubiquitous- and hypodermis-
expressing constructs rescued the perdurance of apoptotic cell corpses in ced-1 null 
embryos, confirming the ced-1 construct is functional (Figure 3S.3A).  
 The ALA axon was cut into multiple sections, as described above. After 24 hrs, 
the worms were reimaged and the amount of axonal debris was quantified. Both the 
ced-1(e1735); oxEx81 parent strain and the neuronal rescue strain had perduring 
axonal debris (4.1 +/- 0.5 debris pieces/100 µm and 3.6 +/- 0.5, respectively), whereas 
the hypodermis and ubiquitous ced-1 expressing strains were rescued for the 
engulfment of axonal debris (Figure 3.6. p< 0.0001 Kruskal-Wallis test). The 
hypodermal rescue of ced-1 reduced the amount of axonal debris by 85% (0.6 +/- 0.2), 
indicating that the hypodermis is responsible for engulfing the vast majority of debris 
following neuronal injury. The ubiquitous rescue of ced-1 dropped the amount of debris 
by an additional 12% (0.13 +/- 0.04), suggesting that some other cell types may 




There are several main conclusions from our data. First, both ced-1 and ced-6 
are consistently required for the engulfment of debris during axon degeneration in C. 
elegans. Second, ced-7 is only involved in engulfment during genetically-induced 












Figure 3.6. Hypodermal cells engulf 
degenerating axons. (A) ALA axons were cut 
into multiple pieces in L2 worms. After 24 hrs, 
the worms were imaged and the amount of 
axonal debris was quantified. A single copy 
insert of ced-1 cDNA in a null mutant background 
rescues axonal debris clearance if expressed 
ubiquitously (Peft-3) or in the hypodermis (Pdpy-
7) but not when expressed in neurons (Prab-3). 
Examples of persisting axonal debris are 
indicated by dashed circles and arrowheads 
mark examples of large axon pieces that have 
not degenerated. The dotted yellow line indicates 
where the out of focus dorsal or ventral nerve 
cord would be. Asterisk indicates gut 
autofluorescence. All worms are expressing 
oxEx81 [Pacr-5::GAP4340aa::GFP]. (B) Wild-
type worms have very few pieces of axon debris 
24 hrs after axotomy. ced-1(e1735) mutants 
have an accumulation of axonal debris, which 
was not rescued by the neuronal expression of 
ced-1. Both the hypodermal and ubiquitous 
rescuing transgenes significantly reduced the 
amount of debris in ced-1 mutants (p < 0.0001 
Kruskal-Wallis test with Dunn’s multiple 
comparisons, *** p<0.001 and **p<0.01 
compared to ced-1(e1735)). 
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pathway does not play a role in clearing degenerating axons in C. elegans, suggesting 
that epithelial cells are uniquely regulated during degeneration compared to 
macrophages and glial cells. To our knowledge, this is the first time the Rac1 pathway 
has been found not to play a role in engulfment. Four, caspases may be involved in 
fragmenting broken axons during neurodegenerative disease. Lastly, hypodermal cells 
engulf degenerating axon debris in C. elegans. The hypodermal cells of the worm are 
analogous to epithelial cells, which have been shown to engulf pruned and injured 
dendrites (Han et al., 2014) and ovary germline cells in Drosophila (Etchegaray et al., 
2012). 
 The variable involvement of ced-7 in axon degeneration is particularly intriguing.  
ced-7 was only required for the engulfment of axon debris in beta-spectrin mutants but 
not axotomized axons in otherwise healthy animals. There are several possible 
explanations for this discrepancy.   1) ced-7 may be uniquely involved in forms of 
neurodegeneration but not neuronal injury. In support of this notion, the engulfment of 
necrotic neurons also requires ced-7 function (Chung et al., 2000).   2) ced-7 may not 
be expressed in ALA. ced-7 is the only engulfment gene that is required in both the 
corpse and the engulfing cell (Hamon et al., 2000; Mapes et al., 2012; Wu and Horvitz, 
1998b). If ced-7 is required within the axon corpse for engulfment, but not expressed in 
ALA, then we would not expect to see an engulfment deficiency in its absence.   3) 
Other proteins may be involved in exposing phosphatidylserine (PS) to the axon 
surface. For example, in apoptotic germ cell engulfment, plsc-1 but not ced-7 was 
required for exposing the PS “eat-me” signal on the surface of apoptotic germ cells 
(Venegas and Zhou, 2007).   4) ced-7 may be uniquely involved in beta-spectrin 
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mutants. These worms are very sick and much of the nervous system is undergoing 
degeneration. It is possible that in such an environment, cells expressing ced-7 may 
become highly reactive and begin to contribute to axon debris engulfment, which they 
would not normally due in a healthy worm. 
 Unlike what has been demonstrated in Drosophila (Ziegenfuss et al., 2012), the 
ced-2, -5, -12 pathway is not involved in axon debris removal in C. elegans. It is 
possible that these genes are no longer expressed in worms after embryogenesis. 
However, this is not likely to be the case. The pathway has a continued role in gonad 
cell corpse removal in adults (Reddien and Horvitz, 2000; Wu and Horvitz, 1998a; Wu et 
al., 2001) and ced-5 expresses in the adult hypodermis (data not shown). Alternatively, 
mtm-1 could be suppressing the pathway in adult worms. MTM-1 has been shown to 
inhibit engulfment by negatively regulating the CED-5, -12 GEF complex (Neukomm et 
al., 2011; Zou et al., 2009). We speculate that epithelial cells may be differentially 
regulated during axon degeneration compared to apoptosis. 
 Who is acting to rearrange the hypodermal cytoskeleton if not the CED-2, -5, -12 
engulfment pathway and CED-10/Rac1? There are two other rho GTPases that could 
be acting within the hypodermal cells to rearrange the cytoskeleton and engulf 
degenerating axons; RhoA and Cdc42. While RhoA (rho-1) has never been shown to 
have a role in apoptosis in C. elegans, experiments with mammalian macrophages 
indicate a duplicitous role for RhoA in engulfment. Inhibitors of RhoA block complement 
receptor mediated phagocytosis (Caron and Hall, 1998; May et al., 2000) but enhance 
the engulfment of apoptotic cells (Leverrier and Ridley, 2001; Nakaya et al., 2006; 
Tosello-Trampont et al., 2003). Thus, RhoA promotes phagocytosis via the complement 
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receptor, but inhibits the engulfment of apoptotic cells. Cdc42 is required for 
phagocytosis in mammalian cells (Caron and Hall, 1998; Leverrier and Ridley, 2001; 
Massol et al., 1998) and for engulfment of embryonic apoptotic cells in C. elegans 
(Hsieh et al., 2012). Interestingly, cdc-42 and its upstream mediators pat-2 and uig-1 
are required in muscle cells and not epithelial cells. This makes them an unlikely 
candidate for the engulfment of axonal debris; however, it is possible that there could be 
a developmental switch that would allow them to be active in nonembryonic epithelial 
cells. Cdc-42 has been shown to function within epithelial cells during the engulfment of 
apoptotic cells in human cell culture lines (Fiorentini et al., 2001). Alternatively, 
GTPases outside of the Rho family could be involved; mutations in ARF and Rab 
GTPases can impair phagocytosis by macrophages (Beemiller et al., 2006; Cox et al., 
2000; Zhang et al., 1998). None of the above GTPases have been shown to regulate 
the engulfment of degenerating axons or dendrites. 
 In conclusion, we show that the epithelial cells of the worm uniquely engage a 
single apoptosis engulfment pathway (ced-1 and ced-6) for removing axonal debris 
during degeneration. In addition, ced-7 may have a context-dependent role in axon 
degeneration. Little is known about the regulation of engulfment during the degeneration 
of neuronal processes. ‘Nonprofessional phagocytes’ were only recently shown to have 
a role in engulfing dendrites (Han et al., 2014). Here we report that they are also 
involved in the removal of degenerating axons. Furthermore, our data suggest that the 





Materials and Methods 
Strains 
 Animals were maintained on E. coli OP50-seeded NGM plates according to 
standard methods. Beta-spectrin mutants were cultured on HB101 or comamonas-




 Plasmids were made using the Invitrogen multisite Gateway cloning technique. 
ced-1 was amplified off of first strand cDNA. The 3,211 bp of ced-1b cDNA, minus the 
stop codon, were inserted into the [1-2] donor vector via BP reaction. The [1-2] ced-1 
cDNA was recombined with [2-3] RFP_let858 3’ UTR, a mosSCI compatible donor 
vector (pCFJ150), and [4-1] vectors containing promoters for either eft-3, dpy-7, or rab-
3. The expression vectors were then inserted into the worm genome at single-copy 
using the mosSCI technique (Frøkjær-Jensen et al., 2008). The ced-1 transgene was 
crossed out of the unc-119 background and into the ced-1(e1735); oxEx81 strain. 
 The oxEx81 transgene (Pacr-5::GAP43::GFP) encodes a membrane-bound GFP 
using the 40 aa myristoylation sequence of GAP43 (Knobel et al., 2001). The oxIs12 
transgene contains soluble GFP under the vGAT promoter, Punc-47::GFP. 
 
Imaging 
Worms were immobilized in either 10 mM muscimol or 25 mM sodium azide on 
3% agarose pads. Images were acquired on a Pascal LSM5 confocal microscope or an 
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LSM510 Meta with a 63x 1.4NA oil objective (Zeiss). The whole length of the worm was 
imaged and the maximum intensity projections were tiled together in Photoshop to 
generate a single image per worm. The length of each worm was measured and the 
total number of debris pieces were quantified using the Cell Counter ImageJ plugin. The 
data are presented as the average number of debris pieces per 100 µm. The beta-
spectrin worms were imaged at the fourth larval stage. 
 
Laser axotomy 
 L2 worms were immobilized as described above. For Figure 3.4, axons were cut 
using a pulsing 810 nm light from a Ti:Sapphire laser (Mira900, Coherent) assembled 
on a LSM510 Meta confocal microscope (Zeiss) and focused through a 63x 1.4NA 
objective. For Figure 3.5, axons were cut using a pulsing 355 nm laser (FTSS355-Q3, 
CryLaS GmbH, Germany) assembled on a Nikon D-Eclipse C1, 90i confocal 
microscope with a Nikon 40x 1.3NA objective.  
 The ALA neuron has a single cell body in the head of the worm (dorsal to the 
posterior bulb of the pharynx) and extends two axons along the length of the worm at 
the right and left midline. In all experiments, either the right or left axon was cut and the 
same side of the worm was imaged on the following day. The ALA axon was cut into 
multiple pieces proceeding anterior to posterior, and then the cell body was killed to 
prevent regeneration. Images were acquired immediately after cutting. Worms were 
then recovered from the agarose pad and placed on bacterial NGM plates for 24 +/- 4 
hrs of recovery. Images were acquired on the Pascal confocal (Zeiss) or the Nikon C1 
confocal on the following day. Images were analyzed in ImageJ as described above. 
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When counting the number of perduring large axon segments, the most anterior  
(attached to the cell body) and the most posterior (extending into the tail ganglia) axon 
pieces were not included in the analysis. Only circular fluorescent particles were 
counted as ‘debris’; anything with an elongated shape was classified as a ‘large axon 
segment’. 
 The GABA motor neuron commissures were cut once just below the midline of 
the worm. The cell bodies were then killed to prevent regeneration. Four to five VD/DD 
commissures were cut per worm. The worms were imaged again 24 hrs later and the 
number of commissures still present and the number of debris pieces were quantified. 
The GFP in the GABA motor neuron experiments is soluble and on occasion would leak 
out of the commissures immediately following the injury. Images were acquired 
immediately after the axotomy and only commissures that were still visible were 
included in the 24 hr analysis. 
 
Statistics 
 Nonparametric tests were used for the following reasons. Nonparametic 
ANOVAs (Kruskal-Wallis Test) were performed for the ced-1, -6, -7 data in Figure 3.1 
and the ced-1 rescue data in Figure 3.6 because the data did not pass the Bartlett’s test 
for equal variances. A nonparametic ANOVA (Kruskal-Wallis Test) was performed for 
the axotomy data in Figure 3.4 because the samples did not have equal variance and 
the wild-type data were not normally distributed. Dunn’s multiple comparisons tests 
were performed between samples in each of the examples listed above. For 
paramentric one-way ANOVAs, Dunnett’s multiple comparisons tests were used, 
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comparing the data to the control sample. For the ced-1 GABA motor neuron axotomy 
data (supplemental data), a nonparametric Mann-Whitney test was used because the 
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Figure 3S.1. ced-3 caspase pathway in beta-spectrin mutants. (A) and (B) contain 
three separate data sets illustrating that mutations in the killing phase of the apoptosis 
pathway do not increase dorsal cord coverage on their own. The increase in dorsal cord 
coverage is only seen when both the engulfment pathway (ced-1) and the caspase 
pathway are mutated (Figure 3.3). (C) If fragmentation is impaired in ced-1; ced-3 
double mutants then we would expect to see an increase in the number of large 
detached axon segments. This analysis includes a survey of all broken axons in the 
worm rather than looking at just the dorsal cord. However, there is no difference in the 
number of large axon segments per worm in the ced-1, killing phase double mutants 
compared to ced-1 alone. (n.s. Kruskal-Wallis test) (D) If ced-3 mutants are impaired for 
axon fragmentation, then we would expect to see a decrease in the amount of axonal 
debris. Axonal debris is slightly decreased in ced-1; ced-3 mutants and significantly 
decreased in ced-1; ced-9 double mutants compared to ced-1 alone. (p= 0.04 One-way 
ANOVA with Dunnett’s multiple comparisons against ced-1 *p< 0.05) (E) The average 
number of commissures per worm is increased in ced-1; ced-3 double mutants. (p= 
0.035 One-Way ANOVA with Dunnett’s multiple comparisons against ced-1 *p< 0.05). 
All worms contain unc-70(s1502) and all worms in C-E are also ced-1(e1735). N= total 
number of worms. [An increase in commissures plus an increase in dorsal cord 
coverage seems to suggest one of two things i) ced-3 increases regeneration in ced-1 
mutants. However, this would be the opposite of what the Driscoll lab has shown for the 
role of ced-3 in regeneration. ii) Loss of ced-3 inhibits the breaking of beta-spectrin 















Figure 3S.2. Axotomy of ALA and GABA motor neuron axons.  (A) The number of 
large axon segments remaining after axotomy of the ALA axon is unchanged across the 
ced genotypes. (B) ced-1 is required for the clearance of GABA commissure debris 
following axotomy. GABA motor neurons extend axons from the ventral nerve cord 
across the lateral side of the worm (commissures) up to the dorsal side where they 
branch out to form the dorsal nerve cord. Individual commissures were cut with a laser 
just below the midline of the worm, four commissures per worm. The worms were 
allowed to recover for 48 hrs and then reimaged. The amount of debris from 
degenerating commissures was quantified. The worm in the image is shifted so that its 
dorsal side is facing towards the objective. Examples of commissure debris are 
indicated with the dashed circle. The asterisk marks autofluorescence from the gut. (C) 
ced-1(e1735) mutants had nearly 8-fold greater amounts of debris compared to the wild 

















Figure 3S.3. ced-1 rescuing construct is functional. (A) The ced-1::rfp mosSCI 
inserts were crossed into ced-1(e1735); oxIs12. The images were taken from strains 
that were homozygous for ced-1(e1735) but still heterozygous for the ced-1::rfp inserts. 
ced-1::rfp was expressed under the eft-3 promoter (ubiquitous expression) and dpy-7 
promoter (hypodermis). NonRFP embryos had apoptotic cell corpses (arrowheads), 
whereas embryos positive for RFP were rescued for corpse engulfment. Images were 
acquired on a wide-field microscope. The strains were homozygosed for the mosSCI 
inserts prior to the axotomy experiments. (B) The number of large axon segments 

















The aim of this dissertation was two-fold; one, to establish C. elegans as a 
model system for studying axon degeneration, and two, to uncover molecular 
mechanisms mediating axon degeneration. Axons degenerate in C. elegans by 
undergoing the same morphological changes that are seen in Wallerian 
degeneration. In other words, they swell, bead, dissociate, and are cleared away. 
Axon degeneration in the worm includes other common characteristics. After an 
injury, an axon will degenerate depending on the location of its mitochondria. The 
presence of mitochondria robustly suppresses axon degeneration in C. elegans 
(Chapter 2). Studies from other model systems, including mammals and flies, 
have similarly demonstrated that mitochondria regulate axon protection (Fang et 
al., 2012; Misko et al., 2012; Schon and Przedborski, 2011). When an axon 
degenerates, other cells clear away the fragmented pieces by engulfment. The 
engulfment of axon debris in C. elegans is regulated by ced-1 and ced-6 
(Chapter 3), similar to what has been observed in Drosophila (Awasaki et al., 
2006; Hoopfer et al., 2006; Macdonald et al., 2006). Thus, the nematode C. 
elegans is a useful model system for studying conserved mechanisms of axon 
degeneration following axotomy.  
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In addition, the data presented in this dissertation delineate several 
advancements. In Chapter 3, we show that epithelial cells engulf degenerating 
axons and that this process is uniquely regulated compared to engulfment during 
apoptosis and during glia-mediated engulfment of degenerating axons. Namely, 
the ced-2 and ced-10 cytoskeleton-rearranging pathway is not involved in 
clearing degenerating axons by epithelial cells, suggesting that these cells 
employ a novel mechanism for engulfment. The data also reveal a specific role 
for ced-7 during neurodegenerative disease and not following an injury. In 
Chapter 2, we identify ric-7 as a novel regulator of mitochondria distribution in C. 
elegans neurons. Using ric-7 as a tool to study degeneration, we demonstrate 
that mitochondria are not required for the break down of axons following injury. 
The presence of mitochondria robustly protects axons in both mutants and the 
wild type, highlighting the critical need for mitochondria in axon maintenance. 
 
Mitochondria-Dependent Mechanism of Axon Protection 
The presence of mitochondria strongly suppresses axon degeneration in 
C. elegans. Some studies have suggested that mitochondria are a required 
participant in the destruction of axons (Barrientos et al., 2011; Keller et al., 2011). 
However, our results demonstrate that mitochondria are dispensable for the 
execution of axon degeneration; instead, they are actively involved in preventing 
degeneration from occurring. How might mitochondria be acting to suppress 
axon degeneration? They could be protective through some direct property of the 
organelle itself, such as energy supply or calcium buffering. Alternatively, 
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molecules associated with mitochondria may be involved in halting axon 
destruction pathways. In the latter model, the mitochondria’s function is to 
localize the antidegeneration signal along the axon.  
 
Oxidative phosphorylation 
Energy supply is unlikely to be the rate-limiting step of axon degeneration. 
Mitochondria dysfunction has been frequently associated with neurodegenerative 
disease and the topic has received much attention. ATP supply from 
mitochondria is critical to the cell and complete abolishment of oxidative 
phosphorylation is cell lethal. However, moderate perturbations do not seem to 
make neurons susceptible to neurodegeneration. Nonlethal mutations in humans 
are not associated with neurodegenerative diseases (Schon and Przedborski, 
2011). Strong hypomorphic alleles in electron transport chain subunits did not 
exhibit elevated axon degeneration following injury in C. elegans (Figure S4.4). 
Furthermore, some studies suggest that neurons can rely heavily on glycolysis in 
the absence of oxidative phosphorylation (Calupca et al., 1999; Fünfschilling et 
al., 2013; Misko et al., 2012; Rangaraju et al., 2014; Tekk k et al., 2003; Winkler 
et al., 2000). 
 
Calcium buffering 
Several pieces of evidence support a role for mitochondria in buffering 
calcium during degeneration. In general, calcium is a well-known mediator of 
degeneration and is tightly regulated by the cell (reviewed in Wang et al., 2012; 
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Zündorf and Reiser, 2011). Application of calcium channel blockers or calcium 
chelators abates axon degeneration (Barrientos et al., 2011; George et al., 1998; 
Knöferle et al., 2010). During homeostatic conditions, the amount of calcium in 
mitochondria is quite low, but they are capable of taking up large amounts of 
calcium when necessary (Montero et al., 2000; Pivovarova et al., 1999). Isolated 
mitochondria from WldS mice are able to load significantly greater amounts of 
calcium, suggesting that the calcium capacity of mitochondria might be related to 
the protective effects of WldS (Avery et al., 2012). Mitochondria uptake calcium 
through the voltage dependent anion channel (VDAC) and the mitochondria 
calcium uniporter (MCU) (Calì et al., 2012). Blocking these channels with DIDS 
and Ruthenium Red reduced axon degeneration in severed sciatic nerves 
(Barrientos et al., 2011). However, VDAC has also been identified in the ER and 
Ruthenium Red targets multiple proteins, including Ryanodine receptors and 
TRP channels (Ding et al., 1998; Dray et al., 1990; Shoshan-Barmatz et al., 
2004).  
Thus far, the evidence supporting an essential role for mitochondria in 
buffering calcium during axon degeneration remains relatively indirect. 
Experiments using specific knockdown of MCU are needed. Also, live imaging of 
mitochondrial calcium levels would reveal the temporal and spatial characteristics 
of calcium uptake following an axon injury. Smooth endoplasmic reticulum (ER) 
is located along the entire length of axons (including in ric-7 mutants, Figure 4.1); 
thus, it is intriguing that mitochondria would have an essential role in buffering  
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calcium after an injury. Imaging of two color calcium reporters is needed to 
elucidate the calcium dynamics between these two organelles. Using 
mitochondria-localized GCaMP and ER-localized R-GECO, the calcium flux in 
each of these organelles can be simultaneously observed in response to an axon 
injury. Do both organelles respond to the increase in cytosolic calcium? Are their 
buffering capacities temporally distinct? 
If ric-7 mutant axons have enhanced degeneration due to reduced calcium 
buffering, the following predictions can be made for future experiments. 1) In 
wild-type axons, mito-GCaMP6 fluorescence should increase following axotomy. 
2) Worms with cell-specific knockdown of the MCU channel should have 
enhanced levels of degeneration, similar to ric-7. 3) Blocking calcium entry into 
the axon should suppress degeneration in ric-7 mutants. Thus far, blocking the L-
type voltage gated calcium channel EGL-19 with the drug Nemadipine-A and the 
egl-19(n582) mutation were unable to suppress degeneration in ric-7 mutants. 
Figure 4.1. Endoplasmic reticulum is located throughout axons. Worms 
are expressing GFP-tagged PISY-1 in the GABA neurons under the unc-47 
promoter. Worms were imaged with their ventral or dorsal side facing the 
objective. The black and white fluorescent images are inverted. ER can be 
seen throughout the entire length of axons in both the ventral nerve cord 
(VNC) and dorsal nerve cord (DNC). ER localization is normal in ric-7 mutants 
(right column). Arrowheads mark cell bodies and arrows point to axons.  
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unc-2 mutants remain to be tested and perhaps both channels need to be 
impaired in order to prevent axon degeneration. 
 
Novel mechanisms of protection 
Lastly, mitochondria may be serving a protective function by localizing an 
unidentified axon-survival factor along axons. These three proposed mechanisms 
of protection are not mutually exclusive and more than one may be at play in 
abating degeneration. C. elegans is an ideal model system in which to screen for 
novel regulators of degeneration. Both beta-spectrin and ric-7 mutants will lend 
themselves well to forward genetic screens.  
 
RIC-7 Mechanism  
Why are mitochondria absent in ric-7 mutant axons? In ric-7 mutants, 
mitochondria are unable to exit the neuronal cell bodies. There are three simple 
models that could explain this phenotype. 1) Fission. The mitochondria are 
unable to divide within the cell body. RIC-7 may promote mitochondrial fission 
and the smaller mitochondria are then able to transport down the narrow axons. 
2) Anchor removal. The mitochondria within the cell body may be tethered in 
place. RIC-7 could be involved in releasing the mitochondria from their anchor 
before they can transport down axons. 3) Transport. RIC-7 may be involved in 
associating mitochondria with the kinesin motor.  
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Fission 
 The first model predicts that RIC-7 is contributing to mitochondrial fission. 
Fission is a highly regulated process of dividing mitochondria in two through the 
constriction of membranes at the fission site (reviewed in Bliek et al., 2013). Drp1 
(dynamin-related protein 1) is a well-characterized mediator of mitochondrial 
fission, originally characterized in yeast (Dnm1) and mammalian cells (Bleazard 
et al., 1999; Otsuga et al., 1998; Smirnova et al., 1998). Dnm1/Drp1 accumulates 
at fission sites and forms spirals around the mitochondrial outer membrane. As 
the spiral tightens due to GTPase activity, the membranes on either side of the 
spiral are pinched off from one another (Ingerman et al., 2005). 
The fission model predicts that ric-7 mutants will phenocopy drp-1 mutants 
and that mitochondria exit from cell bodies is dependent upon fission. To address 
these questions, we examined drp-1 loss of function in GABA motor neurons. 
Null mutations in drp-1 are lethal, so a dominant negative version of the protein 
DRP-1(K40S) was cell-specifically expressed at high concentrations. The 
mitochondria distribution in DRP-1(K40S) neurons is strikingly dissimilar to that of 
ric-7 mutants. In dominant negative DRP-1(K40S) worms, the mitochondria 
extend out of the cell body as long continuous tubules (Figure 4.2). The tubules 
are of varying lengths, but often cover the entire ventral length of the GABA 
motor neuron axons. Thus, instead of a loss of axonal mitochondria, DRP-
1(K40S) animals have an excess of mitochondria in their proximal axons. These 
contrasting phenotypes indicate that ric-7 is not required for fission, and that 
fission is not a prerequisite for exit of mitochondria from neuronal cell bodies.  


















Figure 4.2. ric-7 phenocopies transport mutants and not fission 
mutants. (A) Mitochondria are distributed throughout the ventral nerve cord 
in the wild type but are absent from axons in both kinesin-1/unc-
116(rh24sb79) and ric-7(n2657) mutants. Mitochondria are present in the 
axons of worms overexpressing a dominant negative form of DRP-1(K40S), 
but they are long, continuous tubules that extend along the ventral cord. If 
transport is blocked, then the tubules no longer extend out of the cell body 
‘kinesin-1; DRP-1(K40S)’. Similarly, removing ric-7 also prevents extension 
of mitochondria tubules in DRP-1(K40S) worms. (B) The percent of GABA 
motor neurons with long tubular mitochondria. N = the number of worms, n = 
the number of neurons assayed. 
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Anchor removal 
The second model postulates that RIC-7 is acting to displace a 
mitochondrial tether within the cell body. Once the mitochondria are released 
from their tether, they can be transported down axons. anc-1 is required to 
anchor mitochondria in both hypodermal and muscle cells (Hedgecock and 
Thomson, 1982; Starr and Han, 2002). The muscle mitochondria in an anc-1 
mutant can be seen floating around the cell during muscle contractions. 
Unanchored mitochondria also tend to be spherical and clustered together, 
whereas muscle mitochondria are typically a network of interconnected tubules. 
Because anc-1 appears to be expressed in all adult somatic cells (Starr and Han, 
2002), it is likely that ANC-1 is anchoring mitochondria within neurons as well. If 
RIC-7’s function is to displace the anchor, then genetically ablating the anchor 
should free the mitochondria and make them available for transport. While the 
mitochondria in wild-type neuronal cell bodies typically form a ring around the 
nucleus, the mitochondria in anc-1(n1614) mutants are often clustered to one or 
both sides of the nucleus (not quantified, Figure 4.3C), suggesting that anc-1 
might be required for mitochondria stability in GABA motor neuron cell bodies. 
However, anc-1 does not rescue the localization of mitochondria in ric-7 mutants 
(Figure 4.3D). This suggests that RIC-7 does not release mitochondria from a 
cell body anchor. Very little is known about how mitochondria are stabilized at 
specific locations within neurons. It remains plausible that RIC-7 is regulating an 
unidentified mitochondria anchor. Such an anchor should be identifiable from 
future ric-7 suppressor screens. 









Figure 4.3. anc-1 does not suppress ric-7. (A) In wild-type worms, 
mitochondria are located in cell bodies (arrowheads) and along axons 
(arrow). (B) In ric-7 mutants, the mitochondria are sequestered to the 
cell bodies. (C) Mitochondria are located along axons in anc-1 mutants. 
The mitochondria in the cell bodies to the far right and far left appear to 
be clustered at one or both ends of the nucleus. The asterisk indicates 
autofluorescence from the gut. (D) In anc-1; ric-7 double mutants, the 
mitochondria are still trapped within the cell bodies. All worms are 
expressing Punc-47::Tom20::GFP ‘mito::GFP’. Worms were imaged 
with their ventral nerve cord facing the objective.  
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Transport 
Thus far, the data support the third model for RIC-7 function, namely that it 
is required for mitochondrial transport. Much like kinesin-1 mutants, there is a 
near total loss of mitochondria in ric-7 mutant axons. Instead, the mitochondria 
appear to be trapped and accumulated within the neuron cell bodies. On 
occasion, there will be one or two mitochondria that have exited the cell body; 
however, they are typically located at very short distances from the cell body 
(arrow, Figure 4.3B). This suggests that the mitochondria are not able to move 
very far along the axon, even if they do manage to exit the cell body. The few 
mitochondria that exit the cell body in kinesin-1 mutants are similarly localized. It 
is possible that these mitochondria are being carried small distances by myosin 
motors, which are known to locally transport mitochondria along actin (Zinsmaier 
et al., 2009). 
Further support for the role of RIC-7 in transport comes from the dominant 
negative DRP-1 experiments. The long mitochondria tubules in DRP-1(K40S) 
worms could be extending along the axons by pushing their way out as 
mitochondria biogenesis continues in the cell body, in other words, by passive 
displacement. Alternatively, the long tubules could be transported down the axon. 
The data strongly support the latter scenario. Long tubular mitochondria do not 
extend out of cell bodies in kinesin-1; DRP-1(K40S) double mutants (Figure 4.2). 
This demonstrates that the mitochondrial tubule extension is dependent upon 
transport by kinesin motors. The mitochondrial tubules are also absent in ric-7; 
DRP-1(K40S) double mutants, suggesting that ric-7 is also involved in 
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mitochondrial transport (Figure 4.2). 
In addition, ric-7 can be acutely rescued. Expressing ric-7 under a heat 
shock promoter can rapidly restore mitochondria transport in the GABA motor 
neurons of ric-7(n2657) mutants. L4 worms were heat shocked for 1 hr at 32°C. 
Time-lapse confocal recordings were then taken over the next hour. Each worm 
was recoded for 10 minutes. After heat shock, mobile mitochondria were seen in 
9 out of 12 worms and all worms had mitochondria restored in their proximal 
axons (Figure 4.4). Worms carrying the rescue array but without heat shock 
treatment were not rescued for axonal mitochondria (0/30 worms). Such rapid 
rescue of transport implies that there may not be many steps between RIC-7’s 
function and transport of mitochondria. Taken together, the data thus far suggest 
that RIC-7 plays a role prior to or during mitochondrial transport.  
 
Mitochondrial Transport 
Miro and Milton 
There are three known adaptors for mitochondrial transport; Miro, Milton, 
and Syntabulin (Guo et al., 2005; Stowers et al., 2002). Miro contains two EF-
hand motifs flanked by GTPase domains, and is inserted into the mitochondrial 
outer membrane at its C-terminus (Fransson et al., 2003; Frederick et al., 2004). 
Milton can bind to both Miro and kinesin (Glater et al., 2006); thus, together these 
two proteins create a bridge between mitochondria and kinesin. Miro can be 
regulated by calcium via the EF-hand motifs (Saotome et al., 2008). There are  
 








Figure 4.4. Acute rescue of ric-7 using a heat shock promoter. (A) The ric-
7 rescue construct was placed under a heat shock promoter (Phsp16-41). (B) 
L4 worms were heat shocked for 1 hr in a 32°C water bath. Worms were then 
mounted on 10% agarose pads and immobilized with microbeads. 
Mitochondria transport in the ventral nerve cord of GABA motor neurons was 
recorded on a Nikon spinning disk confocal. All worms were imaged for 10 min 
and within the first hour after heat shock. (C) Mitochondria transport is rapidly 
restored in ventral nerve cord axons following heat shock. The orange 
arrowhead points to a mitochondrion that is transporting down the axon. The 
other two mitochondria are stable. (D) Kymographs representing an entire 
individual experiment. The y-axis is time and the x-axis represents the location 
of the mitochondria along the axon. Straight vertical lines correspond to 
mitochondria that were stable throughout the recording. Slanted lines 
correspond to mobile mitochondria. The majority of mitochondria in a wild type 
are stable, whereas a greater percentage of mitochondria can be seen 
transporting in ric(n2657); hsp::ric-7 following heat shock. (E) The percent of 
mitochondria that are mobile over 10 min in the GABA motor neuron ventral 
nerve cord. Mean (black horizontal line) +/- SEM. On average, 27% of 
mitochondria are mobile in wild-type worms. There is a slight increase in 
mobility following heat shock. A greater percentage of mitochondria are mobile 
following heat shock rescue of ric-7(n2657) mutants. The average percent of 
mitochondria that are mobile is the same in the constitutive rescued worms 
[ric-7(n2657); Punc-47::RFP::RIC-7, ‘RIC-7(+)’] compared to wild type. The 
number of animals is indicated above. N= number of animals. n= number of 
time lapse recordings. (F) Heat shock induced rescue of ric-7 restores the total 
number of mitochondria per 50 µm to wild-type levels. Without heat shock, 
0/30 worms were rescued for mitochondria localization in axons. Time-lapse 
recordings were not taken of these animals, but from previous experiments, 
we know that the number of mitochondria per 50 µm is close to zero in ric-
7(n2657) (see Figure 3.2). The same n values apply as in the graph above. 
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two different models for how calcium is negatively regulating transport through 
Miro. In one study, Miro was shown to bind directly to the kinesin motor KIF5 and 
this interaction is inhibited in the presence of calcium (MacAskill et al., 2009). 
Thus, in the presence of calcium mitochondria disassociate from kinesin. 
However, a second study using Drosophila Milton within mammalian systems 
proposes a different model (Wang and Schwarz, 2009). They show that human 
Miro cannot bind to rat KHC (kinesin heavy chain) unless Drosophila Milton is 
present. In the presence of calcium, the kinesin motor domain dissociates from 
microtubules and binds to Miro. They also show that all mitochondria, even 
stationary ones, are associated with kinesin. Together the data suggest that 
calcium mediated transport arrest is due to kinesin dissociation from 
microtubules rather than from a mitochondria transport complex (Wang and 
Schwarz, 2009).  
 
Syntabulin 
Syntabulin is a single adaptor protein that binds to kinesin 1 and can 
associate peripherally with the mitochondria membrane (Cai, 2005; Su et al., 
2004). Cultured neurons expressing siRNA against syntabulin have reduced 
numbers of mitochondria in processes and disrupted mitochondrial transport 
(Cai, 2005; Ma et al., 2009). Axons expressing siRNA against syntabulin have an 
increase in stable mitochondria and a dramatic decrease in the percent of 
mitochondria that are transporting anterogradely (Cai, 2005). It is not known how 
the function of syntabulin overlaps with, or differentiates from, that of Miro and 
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Milton. Syntabulin also has a reduction in syntaxin and active zone puncta in 
axons (Cai et al., 2007; Su et al., 2004). It would be interesting to know if these 
two results are related. Could it be that there are reduced mitochondria in axons 
because there are fewer synapses, or vice versa? Syntabulin exists solely in 
vertebrates and appears to be rapidly diverging, with only 44% identity between 
mice and zebrafish, compared to 80% for Miro. 
 
Mitochondrial transport in C. elegans 
Miro and Milton do not have a confirmed function in mitochondrial 
transport in C. elegans. There are three genes that encode Miro homologs in the 
worm. These genes appear to be the result of a duplication of the Miro gene 
since they are nearly identical. Deletion mutations in each are viable; however, 
RNAi against miro is lethal, suggesting that they act redundantly. We have 
examined a deletion mutant for miro-1 and the mitochondria are transported into 
the GABA motor neuron axons. It is possible that the removal of all three miro 
genes would result in a severe mitochondrial trafficking defect if the worms were 
viable. 
The Milton homolog in the worm is T27A3.1, which is 32% identical to the 
mouse TRAK1 (trafficking protein kinesin-binding) and 24% identical to 
Drosophila Milton. The mutation tm1572 contains a 706 nt deletion beginning in 
the middle of the conserved coiled-coil domain that has been shown to bind 
Kinesin (Smith et al., 2006), followed by a frameshift and a premature stop codon 
a few amino acids later. Thus, the tm1572 allele is likely to be a null mutation due 
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to nonsense-mediated decay. Surprisingly, the mutant does not exhibit a 
profound defect in mitochondria localization in motor neurons. On occasion, there 
are increased gaps between mitochondria in the dorsal nerve cord (Figure 4.5), 
but in general, the mitochondria are able to transport out into axons. While Milton 
mutants have very severe losses of mitochondria in the fly, knock down of both 
TRAK1 and 2 in mammalian neurons results in transport abnormalities but not a 
total loss of mitochondria (Brickley and Stephenson, 2011; van Spronsen et al., 
2013). The mammalian TRAK proteins are weakly homologous to Drosophila 
Milton, with just 22% identity (MacAskill et al., 2009). It is likely that T27A3.1 is 
more similar in function to TRAK than Drosophila Milton.  
 
 
       
         
Figure 4.5. C. elegans milton mutants have minor defects in 
mitochondrial localization. mito::GFP is expressed in the GABA 
neurons. Worms were imaged with their dorsal side facing the 
objective. The dorsal nerve cord represents the most distal portion 
of the GABA motor neuron axons. (A) In wild-type worms, 
mitochondria are evenly distributed along the dorsal nerve cord. (B) 
In milton mutants, the mitochondria are usually properly localized. 
(C) Occasionally, gaps in the coverage of the dorsal nerve cord are 
observed. 	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Since RNAi against miro is lethal and it is highly conserved from humans 
to yeast, it seems very likely that miro will also be required for mitochondrial 
transport in C. elegans. But how is Miro interacting with kinesin if the closest 
Milton homologue is not involved? Can C. elegans MIRO directly bind to 
Kinesin/UNC-116 as demonstrated by the Kittery lab (MacAskill et al., 2009)? Or 
could another protein be serving the function of Milton in C. elegans, such as 
RIC-7? If RIC-7 is serving as a bridge between the kinesin motor and the 
mitochondria, then we should be able to see RFP::RIC-7 transporting along with 
mitochondria. In C. elegans GABA motor neurons, 27% of mitochondria in the 
ventral nerve cord are mobile. However, RFP::RIC-7 was not seen transporting 
along the axons. Future genetic screens and biochemistry experiments are 
needed in order to resolve RIC-7’s mechanism. Establishing the interaction 
partners for RIC-7 may uncover a novel mechanism for regulating mitochondrial 
transport in neurons. 
 
Mitochondrial Transport and Neurodegeneration 
 Many neurodegenerative disorders have been linked to mitochondrial 
defects, as discussed in Chapter 1. It is not clear whether these defects are 
secondary effects of disease or whether they could be causative for 
degeneration. Recent studies, including the work in this dissertation, demonstrate 
that defects in mitochondria localization are sufficient to induce degeneration 
(Chapter 2; Fang et al., 2012; Iijima-Ando et al., 2012; Misko et al., 2012). These 
results argue that the disruption of mitochondria transport or localization is 
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causative for degeneration. Of the mitochondrial defects associated with 
neurodegenerative disease, many are related to the transport and localization of 
mitochondria.  
 
Transport machinery mutations 
Some diseases are associated with mutations in the transport machinery. 
Mitochondria transport is disrupted in the absence of the kinesin KIF5A (Karle et 
al., 2012) and the mammalian homolog for Milton has been shown to interact 
with KIF5A (Brickley et al., 2005). Human mutations in KIF5A have been 
identified in families with the hereditary neurodegenerative diseases, spastic 
paraplegia and Charcot-Marie-Tooth type 2 (Crimella et al., 2012; Musumeci et 
al., 2011; Reid et al., 2002). Mutations in the dynactin subunit p150Glued are 
associated with both sporadic and familial forms of ALS (Münch et al., 2004). 
Notably, the mammalian Milton homolog TRAK has recently been shown to bind 




Disruption of the mitochondrial fusion protein Mitofusin2 (Mfn2) causes the 
neurodegenerative disease Charcot-Marie-Tooth type 2 in humans (Cartoni and 
Martinou, 2009). However, mitochondria transport may be more relevent to their 
pathology than fusion. Both mutants and knockouts of Mfn2 have reduced 
mitochondria transport (Baloh et al., 2007; Misko et al., 2010, 2012). Fusion 
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defective mitochondria may have altered transport due to the propensity for 
dysfunctional mitochondria to be transported back to the cell body (Miller and 
Sheetz, 2004). However, the mutant Mfn 2 mitochondria do not display defects in 
membrane potential or ATP levels (Baloh et al., 2007; Misko et al., 2012). In 
addition, Mfn2 can directly interact with the transport adaptor proteins Miro and 
Milton (Misko et al., 2010), and mutant Mfn2 leads to reduced mitochondria 
velocity and increased pause times (Misko et al., 2010). Together the data 
suggest that Mfn2 may have a role in regulating mitochondria transport 
dynamics. Most recently, it was demonstrated that cultured DRG neurons with 
mutant Mfn2 undergo degeneration due to impairments in mitochondria 
distribution and not fusion (Misko et al., 2012). 
 
ALS, Alzheimer’s, and Huntington’s diseases 
In general, mitochondria transport defects have been identified in many 
neurodegenerative disease patients and models, including ALS, Alzheimer’s, and 
Huntington’s. The most common source of familial ALS are mutations in Cu/Zn 
superoxide dismutase-1 (SOD1). SOD1 mutant axons have reduced numbers of 
mitochondria due to a decrease in anterograde and an increase in retrograde 
transport (De Vos et al., 2007). A subsequent study showed that mobility is 
reduced in both anterograde and retrograde directions when neurons were 
expressing mutant human SOD1 (Magrané et al., 2009). Fibroblasts from 
Alzheimer’s patients have fewer and mislocalized mitochondria (Wang et al., 
2008), and postmortem analysis of the hippocampus in patients revealed that 
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mitochondria are largely absent from axons (Wang et al., 2009). An amyloid beta 
precursor protein (AβPP) mouse model revealed a strong reduction in 
anterograde transport of mitochondria (Calkins et al., 2011). There is also strong 
evidence implicating a key role for transport in Huntington’s disease. Expressing 
mutant huntingtin (mHtt) in cultured neurons led to aggregates of mHtt in axons, 
with which mitochondria were preferentially colocalized. Mitochondria that were 
associated with mHtt aggregates were dramatically less mobile, whereas those 
not associated with aggregates had wild-type levels of mobility (Chang et al., 
2006). The velocity of mitochondria transport is also reduced in response to 
mutated Htt and to the knockout (Orr et al., 2008; Trushina et al., 2004).  
However, many of these findings are complicated by other defects, such 
as a general disruption of axonal transport (Gunawardena et al., 2003; Lee et al., 
2004). It was not clear whether the lack of mitochondria is sufficient for 
degeneration. Our results demonstrate that mitochondrial mislocalization is 
sufficient for degeneration. It is possible that mitochondrial dynamics have a key 
underlying role in neurodegenerative diseases. Perhaps more disorders are 
associated with defective mitochondrial transport over mitochondria dysfunction 
than we currently realize. 
 
Mitochondrial transport as a therapeutic target 
Could mitochondrial transport be a therapeutic target for treating 
neurodegnerative disease? If axons are highly susceptible to the mislocalization 
or aberrant transport of mitochondria, then perhaps augmenting their mobility 
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could be neuroprotective. Forcing mitochondria into axons by directly linking 
them to kinesin with a chimeric protein robustly suppressed axon degeneration in 
ric-7 mutants (Figure 2.4). This suggests that enhancing transport can effectively 
treat a mitochondria mislocalization disorder. The axon protective chimeric 
protein WldS has also been linked to mitochondria transport. WldS has many 
effects on the cell, one of which is to increase the number of mobile mitochondria 
following an injury compared to wild type (Avery et al., 2012; O’Donnell et al., 
2013). It is not known whether the increase in transport is required for the 
protective effects of WldS.  
Removal of HDAC6 (histone deacetylase) can also promote transport 
through an increase in microtubule acetylation (Chen et al., 2010; Dompierre et 
al., 2007; Hubbert et al., 2002; Matsuyama et al., 2002). Both kinesin and dynein 
can bind more efficiently to acetylated microtubules and transport is generally 
increased in these mutants (Dompierre et al., 2007). Mitochondrial transport is 
reduced in a HSPB1 Charcot-Marie-Tooth mouse model and inhibiting HDAC6 
improved both mitochondria transport and motor performance (d’ Ydewalle et al., 
2011). HDAC6 inhibitors are also able to augment mitochondrial transport in an 
Alzheimer’s disease model (Kim et al., 2012) and HDAC6 knockout improved 
both memory and mitochondria localization in another AD mouse model 
(Govindarajan et al., 2013). It is not certain whether these mouse models are 
recovering due to a restoration of mitochondrial transport, or whether transport in 
general has to be increased for effective prevention of degeneration. 
Another study indicates that increasing mitochondria transport is not likely 
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to be therapeutic. Mitochondria transport can be increased by removing 
syntaphilin, which blocks transport by anchoring mitochondria to microtubules in 
axons (Chen and Sheng, 2013; Chen et al., 2009). For example, 76% of 
hippocampal mitochondria are mobile in syntaphilin knockouts compared to 36% 
in the wild type (Kang et al., 2008). The ALS mouse model SOD1G93A has a 50% 
reduction in mitochondria mobility in cultured DRG neurons and removing 
syntaphilin can increase mobility to above wild-type levels. However, removing 
syntaphilin did not prevent neurodegeneration of motor neurons in the ALS 
SOD1G93A mice (Zhu and Sheng, 2011). Thus, increasing mitochondria mobility 
may not be a reliable means to prevent degeneration. Evidence suggests that 
hyper-mobile mitochondria are unable to effectively buffer calcium after high 
stimulation (Kang et al., 2008). The mitochondria in the syntaphilin knock outs 
might be similarly unsuited for the demands of a neurodegnerative disease 
model. 
The literature suggests that we are far from understanding the role of 
mitochondria transport in preventing degeneration. The stopping locations and 
exact distribution of mitochondria may be more important in preventing 
degeneration than their mobility (Misko et al., 2012). The transport dynamics of 
mitochondria in the Kinesin::Tom7 transport chimera experiments are unknown. 
Can mitochondria stabilization still be regulated when the organelle is forcibly 
linked to kinesin? Interestingly, of the three existing models for mitochondria 
stabilization, only one could presumably still function in these animals. The three 
models for stabilization are; i) syntaphilin-mediated anchoring to microtubules, 
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but there is no syntaphilin homolog in C. elegans, ii) dissociation of kinesin from 
the adaptor complex, and iii) kinesin motor domain dissociation from 
microtubules and binding to Miro. In ric-7 mutants expressing the Kinesin::Tom7 
transport chimera, kinesin is incapable of dissociating from mitochondria. 
However, the kinesin in the transport chimera could still presumably fold back 
and bind to MIRO on the mitochondria surface (Figure 4.6). If model ii is correct, 
all mitochondria should be mobile in these worms. If model iii is correct, only a 
portion of mitochondria should be mobile. Observing mitochondria transport and 
localization in ric-7; Kinesin::Tom7 worms can additionally answer questions 
about the importance of mitochondria localization in preventing degneration. Do 
the mitochondria have to be docked at synapses or located near the lesion site? 
Or do the mitochondria simply have to be present? In conclusion, ric-7 mutants 
will continue to be a useful tool for studying the rules governing both 
mitochondria dynamics and axon degeneration.   
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